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ABSTRACT 
Male reproductive health is of growing concern, as male toxicant exposure 
can affect progeny outco.me; sperm chromatin structure integrity may be a 
contributing factor. The formation of mature sperm involves the expression of 
numerous proteins involved in organizing and packaging the chromatin in a 
specific manner; this ensures transmission and participation of the paternal 
genome in embryogenesis. Exposure of male rats to cyclophosphamide as 
spermatid chromatin is remodeled has an adverse effect on embryo 
development. The hypothesis of this thesis is that cyclophosphamide exposure 
causes genetic damage and alters the sperm proteome, thus disrupting 
components of chromatin condensation and organization during spermiogenesis. 
The first objective was to assess the phase specificity of the susceptibility of 
spermiogenic germ cells to cyclophosphamide-induced DNA damage. 
Spermatozoa were analyzed for DNA strand breaks using the comet assay. 
Cyclophosphamide-induced DNA damage was dose-related and accumulated 
over time. Germ ce Il phase-specific damage was maximal during mid-
spermiogenesis; this reflects an increased susceptibility of step 9-14 spermatids 
at a key point in sperm chromatin remodeling, the histone-protamine exchange. 
The second objective was to examine the sperm chromatin structure and basic 
proteome. Multiple assays demonstrated that the effects of cyclophosphamide 
on sperm chromatin structure were also germ cell-phase specific; mid-
spermiogenic spermatids were most sensitive. Sperm were less condensed with 
reduced total thiol and protamine contents. The sperm basic proteome was also 
altered; identified proteins are involved in a variety of spermiogenic and 
fertilization events. The nuclear matrix organizes chromatin into loop domains, 
and various components of somatic cel! matrices are targets for 
chemotherapeutic agents. Therefore the last objective of this study was to 
assess the effect of cyclophosphamide exposure on the protein profile of the 
sperm nuclear matrix. The expression of several nuclear matrix protein 
components, a number of which were identified for the first time, was altered 
fol!owing drug exposure. Together these results show that cyclophosphamide 
alters male germ cel! chromatin remodeling at both the DNA and protein level; 
this could alter sperm function and thus explain the adverse effects on early 
embryo development. 
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ABRÉGÉ 
la reproduction masculine devient un enjeu important, sachant que 
l'exposition d'un homme à des composés toxiques peut affecter sa descendance; 
l'intégrité de la structure de la chromatine du spermatozoïde pouvant être un des 
facteurs en jeu. la formation des spermatozoïdes matures nécessite l'expression 
de diverses protéines impliquées dans l'organisation et la compaction spécifique 
de la chromatine, assurant ainsi la participation et la transmission du génome 
paternel lors de l'embryogenèse. l'exposition de rats mâles à la 
cyclophosphamide lors du remodelage de la chromatine dans les spermatides 
induit des anomalies du développement embryonnaire. l'hypothèse de ce travail 
de thèse est que l'exposition à la cyclophosphamide induit des anomalies 
génétiques et protéiques dans les spermatozoïdes, altérant ainsi les acteurs de 
la compaction et de l'organisation de la chromatine lors de la spermiogenèse. le 
premier objectif a été d'établir les périodes de sensibilité lors de la maturation des 
cellules germinales mâles, en terme d'altération de l'ADN, à l'exposition à la 
cyclophosphamide. les coupures d'ADN dans les spermatozoïdes ont été 
analysées par la technique du COMET. la cyclophosphamide induit des 
altérations de l'ADN de façon dose dépendante et s'accumulant avec le temps 
d'exposition. les cellules germinales les plus sensibles sont les spermatides aux 
stades 9 à 14, ce qui correspond à une étape clé du remodelage de la 
chromatine: le remplacement des histones par les protamines. le deuxième 
objectif a été d'observer la structure de la chromatine ainsi que le protéome des 
spermatozoïdes après traitement. Différentes techniques ont confirmé la période 
de sensibilité en mi-spermiogenèse, des cellules germinales à la 
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cyclophosphamide. L'analyse de l'expression des protéines basiques contenues 
dans les spermatozoïdes a aussi révélé des anomalies, certaines protéines étant 
impliquées dans la spermiogenèse et la fertilisation. La matrice nucléaire 
organise la chromatine en boucle, et l'on sait que les agents de chimiothérapie 
peuvent altérer certains composants de cette matrice dans les cellules 
somatiques. C'est pourquoi, le troisième objectif de cette thèse a été d'étudier 
l'effet de la cyclophosphamide sur la matrice nucléaire des spermatozoïdes. 
Nous avons montré que l'expression de nombreux composants étaient affectée, 
certains d'entre eux étant identifiés pour la première fois. L'ensemble de ces 
résultats montre que la cyclophosphamide altère le remodelage de la chromatine 
dans les cellules germinales mâles tant au niveau génomique que protéique. Ces 
effets peuvent modifier la fonction de ces cellules et expliquer ainsi en partie les 
anomalies observer au niveau du développement embryonnaire. 
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CHAPTER 1 
Introduction 
1 
1.1. Male Reproductive System 
The male reproductive system is composed of the testes, the excurrent 
duct system, the accessory sex glands (prostate, seminal vesicles, bulbourethral 
gland and Cowper's gland), and the external genitalia. The testes have two 
functions: male gamete and androgen production. The testes contain convoluted 
seminiferous tubules surrounded by interstitial tissue; the interstitium contains 
Leydig cells which synthesize and secrete testosterone. The seminiferous 
tubules, responsible for gametogenesis, are lined by a stratified epithelium 
consisting of spermatogenic cells and the supporting Sertoli cells, and conta in a 
fluid-filled lumen into which fully formed spermatozoa are released (Russell et al., 
1990). Sertoli cells extend from the basement membrane to the luminal surface 
of the seminiferous epithelium; they establish the blood-testis barrier and support 
the developing germ cells throughout spermatogenesis (Byers et al., 1993). 
Successful and complete male gamete development is dependent on the 
endocrine system of the hypothalamic-pituitary-testicular axis. The hypothalamus 
releases gonadotropin-releasing hormone (GnRH) which acts on the anterior 
pituitary gland to stimulate the release of gonadotropins, luteinizing hormone (LH) 
and follicle-stimulating hormone (FSH). LH acts on the Leydig cells to trigger the 
synthesis and secretion of testosterone. FSH acts on the Sertoli cells to produce 
factors that are essential for normal testicular function (Weinbauer and Nieschlag, 
1995). 
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1.1.1. Male Gamete Development 
Spermatogenesis is a highly synchronized and regulated process by which 
immature male germ cells develop into mature spermatozoa. It can be divided 
into three phases: spermacytogenesis (proliferation), spermatidogenesis 
(meiosis) and spermiogenesis (differentiation). Each phase is also associated 
with specifie germ cell types: spermatogonia, spermatocytes and spermatids, 
respectively. 
1.1.1.1 Spermacytogenesis 
Spermatogonia are the most immature cells located along the base of the 
seminiferous epithelium. They proliferate by mitotic division (3-6 depending on 
the species, 5 in the rat) and multiply repeatedly to continually replenish the 
seminiferous epithelium. In the rat, there are three types of spermatogonia: stem 
cells (Ais), undifferentiating proliferative cells (Apaired and Aaligned) and 
differentiating cells (A1, A2, A3, ~, Intermediate and Type B). It is the Aaligned cells 
that leave the pool of undifferentiated Type A spermatogonia and commit to 
differentiation by undergoing several mitotic divisions. The final mitotic division of 
Type B spermatogonia results in the formation of primary spermatocytes (de 
Rooij and Russell, 2000). 
1.1.1.2 Spermatidogenesis 
Spermatocytes undergo two meiotic divisions to form the haploid 
spermatid. Primary spermatocytes immediately enter prophase of the first 
meiotic division to produce two diploid secondary spermatocytes. The process of 
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meiosis is extended over a long period of time; prophase of the first meiotic 
division lasts for nearly three weeks in the rat (Hess, 1998). To increase the 
genetîc variability of the gamete, recombination or chromosomal crossover 
occurs between paired chromosomes. Secondary spermatocytes rapidly enter 
meiosis /1 and divide to produce four haploid round spermatids (Russell et al., 
1990). 
1.1.1.3 Spermiogenesis and Maturation 
Spermiogenesis is the final stage of spermatogenesis in which haploid 
round spermatids undergo dramatic changes to give rise to spermatozoa; this 
process occurs without cell division. In the rat, over a span of about three weeks, 
the nucleus goes through profound alterations. Depending on the species, the 
sperm nuclear shape varies; spermatozoa in most mammals, including humans, 
have a spatulate head; however, in rodents, they have a falciform or sickle-
shaped head (Lalli and Clermont, 1981; Yanagimachi, 1981). Nuclear shaping 
may be determined or maintained by the formation of the acrosome, manchette 
or perinuclear theca (subacrosomal perforatorium and postacrosomal sheath) as 
spermiogenesis progresses (Bellve and O'Brien, 1983; Longo et al., 1987; Longo 
and Cook, 1991; Russell et al., 1991). Acrosome formation is a slow process that 
is not complete until late spermiogenesis (Lalli and Clermont, 1981; Leblond and 
Clermont, 1952b). The acrosome is of Iysosomal origin and contains a number of 
enzymes responsible for sperm penetration through the layers surrounding the 
egg and sperm-egg fusion (Clermont and Tang, 1985; Yoshinaga and Toshimori, 
2003). The nuclear shape is also a result of chromatin remodeling; round 
4 
elongate and the chromatin condenses as the DNA is repackaged (Ward and 
Coffey, 1991). Spermatids also develop a flagellum made up of microtubules. 
The axoneme, derived from one of the two centrioles, is the core scaffold of the 
flagellum (Fawcett, 1975) (Figure 1-1). 
) 
Nucleus 
Postacrosomal 
sheath 
Postacrosomal 
sheath 
Earlv Spermatid Spermatozoon 
Figure 1-1. The rat spermatid and spermatozoon 
Adapted from de Kretser and Kerr, 1994 and Calvin, 1976 
Spermatozoa are released from the Sertoli cells into the lumen of the 
seminiferous tubules ina process called spermiation. However, prior to 
spermiation the spermatid sheds most of its excess cytoplasm and organelles in 
the residual body, which is phagocytosed by the Sertoli cells (Kerr and de 
Kretser, 1974). Following spermiation the spermatozoa are not motile. They are 
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transported in testicular fluid by peristaltic contractions through the efferent ducts, 
after which they enter the caput (head) epididymidis, progress to the corpus 
(body) and finally reach the cauda (tail) region where they are stored. While they 
travel down the epididymis they undergo maturation; spermatozoal chromatin is 
further condensed and stabilized, and the cells acquire motility and fertilizing 
potential. It takes spermatozoa approximately 8 days to pass through the rat 
epididymis compared to approximately 6 days in man and 15 days in the mouse 
(Hess, 1998; Robaire and Hermo, 1988) . 
1.1.1.4 Classification and Timing of Spermatogenesis 
Spermatogenesis is highly synchronized as evidenced in seriai cross-
sections of seminiferous tubules where germ cells develop in distinct associations 
at a particular point in time. Each association is classified as a stage and each 
stage varies in duration. Spermiogenesis can be divided into developmental 
steps based on the shape of the acrosome, and to a lesser extent on spermatid 
head shape and degree of chromatin condensation. There are 19 steps of 
spermiogenesis in the rat; steps 1-8 are round, steps 9-14 are elongating, and 
steps 15-19 are elongated spermatids. Consequently, each stage can be 
classified based on the steps of spermiogenesis (Leblond and Clermont, 1952a), 
such that steps 1 to 14 occur in stages 1 to XIV of the cycle, respectively. Steps 
15-19 overlap the early round spermatids (Figure 1-2). 
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( Stages of the spermatogenic cycle ) 
Figure 1-2. The rat spermatogenic cycle 
Adapted from Russell et al., 1990 
A spermatogenic cycle is defined as the time it takes for the reappearance 
of the same stage within a given segment of the tubule. Each stage of the cycle 
follows in an orderly sequence along the tubule. The number of stages within a 
spermatogenic cycle varies between and within species; there are 14 different 
stages in the Sprague-Dawley rat lasting 12.9 days, 12 in the mouse lasting 8.6 
days and 6 in man lasting 16 days (Clermont, 1972; Clermont and Leblond, 1955; 
Leblond and Clermont, 1952b). In the rat, the duration of spermatogenesis 
(about four cycles) starting from the stage where proliferating spermatogonia are 
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called differentiating spermatogonia (Aaligned to A1) is 48-52 days, depending on 
the strain. In mice it takes 34.5 days and in man, spermatogenesis is completed 
in 64 days (Clermont et al., 1959). 
1.1.2. Sperm Chromatin Structure 
Ward and Coffey (1991) proposed four levels of organization for 
spermatozoal packaging: (1) chromosomal anchoring, which refers to the 
atlachment of the DNA to the nuclear annulus; (2) replacement of histones by 
protamines to condense the DNA; (3) DNA loop domain formation on the nuclear 
matrix; and (4) chromosomal positioning. The relationship between nuclear 
function and organization has been weil established in somatic cells (Cremer et 
al., 2000); however, the functional significance of sperm structural organization 
remains elusive. Two levels which determine higher chromatin organization 
within somatic nuclei and which play an essential role in gene regulation are 
nucleosomal and DNA loop-domain organization (Demeret et al., 2001). DNA 
organized into nucleosomes has been proposed to be further coiled into bulky 
solenoids with six nucleosomes per turn (Ward, 1993), which then make up 
DNA/soienoid loop domains. In the case of mature spermatozoa, however, the 
DNA is not organized into nucleosomes. Instead of histones, the chromatin is 
packaged with protamines in such a way that the DNA becomes at least six times 
more condensed than that of somatic cell nuclei and occupies almost the entire 
nuclear volume (Ward and Coffey, 1991). It is believed that this compact 
structure serves to protect and allow delivery of the paternal genome to the egg; 
in fa ct , haploinsufficiency caused by a mutation in one allele of the protamine 
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gene prevents the production of structurally and functionally intact sperm (Cho et 
al., 2001). There is increasing interest in sperm chromatin organization as more 
evidence is reported regarding the greater role it may play in embryo 
development. In the following sections, each of these two levels will be 
discussed in greater detail. 
1.1.2.1. Nucleoproteins: Solenoids to Toroids 
1.1.2.1.1. Histones 
Round spermatids contain a complement of somatic-type histones (H 1 , 
H2A, H2B, H3, H4) and testis-specific histones (H1t, H1t2, TH2A, TH2B, TH3) 
(Martianov et al., 2005; Meistrich, 1989). The testis-specific variants replace a 
significant fraction of the somatic-types during mitosis and meiosis (Meistrich et 
\ 
al., 1985). The histones undergo post-translational modifications in order to alter 
their association with DNA (Poccia, 1986); ubiquitination, acetylation and 
phosphorylation are thought to facilitate chromatin transformation from a 
nucleosomal structure to a nucleoprotamine structure during spermatid 
differentiation. Homozygous mutation of the mouse HR6 ubiquitin-conjugating 
enzyme causes abnormal chromatin condensation (Roest et al., 1996). Histone 
H4 is highly acetylated in rat elongating spermatids when histone displacement 
commences, in order to relax the chromatin for interaction of the DNA with more 
basic proteins (Grimes, Jr. and Henderson, 1984; Meistrich et al., 1992). 
Additionally, small serine/threonine protein kinase (SSTK), expressed exclusively 
in elongating spermatids, specifically phosphorylates H1, H2A, and H3 as weil as 
the H2A variant, H2AX (Spiridonov et al., 2005). In many species, including 
9 
humans, 85-90% of histones are removed (Gatewood et al., 1990; Tanphaichitr 
et al., 1978), while in others however, including rats, nearly ail of the histone 
complement is replaced (Meistrich et al., 1994). 
During the histone-protamine exchange, endogenous nicks in DNA are 
created in step 12-13 rat elongating spermatids which are then ligated before the 
completion of protamination (McPherson and Longo, 1993a; McPherson and 
Longo, 1992; McPherson and Longo, 1993b; Sakkas et al., 1995). These nicks 
may be present to facilitate protamination by providing relief of tortional stress 
(McPherson and Longo, 1992). Interestingly, high levels of poly (ADP-ribose) 
formation, mediated by DNA damage-dependent poly (ADP-ribose) polymerases 
(PARP), occur in step 12-13 spermatids (Meyer-Ficca et al., 2005). In PARP-Z'-
mice, spermiogenesis is affected as nuclear elongation is delayed (Dantzer et al., 
2006). Additionally, phosphorylated H2AX is present in rat spermatids at the 
same time that the nicks occur (Meyer-Ficca et al., 2005). Phosphorylated H2AX 
is an indicator of DNA double strand breaks; in fact H2AX phosphorylation even 
occurs in human spermatozoa following hydrogen peroxide induction of DNA 
double strand breaks (Li et al., 2006). Several DNA repair factors have been 
shown to co-Iocalize with phosphorylated H2AX and seem to be implicated in the 
repair of DNA damage (Mladenov et al., 2006; Pauli et al., 2000). The presence 
of both poly (ADP-ribose) and phosphorylated H2AX in rat spermatids may play a 
role in DNA strand break repair during the exchange between nucleoproteins. 
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1.1.2.1.2. Transition Proteins 
The exchange between histones and protamines is not direct; there are 
other players involved in the transition. After meiosis, the beginning of 
spermiogenesis is characterized by a wave of transcriptional activity which results 
in the activation of numerous essential post-meiotic genes in early spermatids 
(Schmidt and Schibler, 1995). In particular, transition protein and protamine 
genes are transcribed and stored in the cytoplasm of round spermatids until they 
are translated days later (Dadoune, 2003; Morales et al., 1991; Steger, 1999). 
Transition proteins are more basic than histones and less basic than protamines. 
Four transition proteins (TNP 1-4) have been identified in the rat (Kistler et al., 
1975); TNP1 and TNP2 are the best characterized forms. TNP2 is the first 
nucleoprotein that replaces the histones. Its appearance is associated with the 
onset of nuclear elongation. In the rat, immunocytochemical analysis shows that 
TNP2 first appears in step 9-11 spermatids followed by high levels in steps 12-
14. It disappears by step 16 (Oko et al., 1996). As the nucleus begins to 
condense, TNP1 is lowly expressed in step 12 and th en peaks in steps 13-15. It 
disappears by step 17 (Heidaran et al., 1988; Kistler et al., 1996; Oko et al., 
1996). 
Functionally, TNP1 and TNP2 knockouts suggest that these two proteins 
are related to each other; in both TNP1-1- and TNP2-1- mice, germ cells are able to 
initiate chromatin condensation (Adham et al., 2001; Yu et al., 2000; Zhao et al., 
2001). Although the absence of either protein is compensated by increased 
levels of the remaining transition protein, epididymal sperm chromatin 
condensation is not complete and is accompanied by abnormal condensation 
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· patterns (Yu et al., 2000; Zhao et al., 2001). Both TNP1 and TNP2 may be 
necessary for maintaining the normal processing of protamine 2 (PRM2) 
precursors (Yu et al., 2000; Zhao et al., 2001); high levels of PRM2 precursors 
have been detected in sperm of infertile men (De Yebra et al., 1998). Targeted 
deletion of the Tnp2 gene results in abnormal sperm head morphology (Adham et 
al., 2001) and altered sperm chromatin structure (Zhao et al., 2001), possibly due 
to increased DNA strand breaks. Interestingly, it has been hypothesized that, 
apart from their role in DNA compaction, TNP1 and TNP2 mayalso be involved 
in the repair of the DNA breaks that occur in elongating spermatids (Caron et al., 
2001; Kierszenbaum, 2001). 
1.1.2.1.3. Protamines 
Two different types of protamines have been identified in mammals, 
protamine 1 (PRM1) and protamine 2 (PRM2). Protamines are very small (-6500 
Da) and highly basic arginine- and cysteine-rich proteins. In many mammalian 
species, including the rat, only PRM1 is present in spermatozoa, although the 
protamine 2 gene sequence exists (Tanhauser and Hecht, 1989); it is the last 
nucleoprotein to appear in mature spermatid nuclei (Balhorn, 1989). PRM1 first 
appears in step 11 elongating spermatids "and persists throughout the rest of 
spermiogenesis; protamine deposition is complete by step 19. The accumulation 
of PRM1 displaces the transition proteins as they preferentiallybind to the minor 
groove of the DNA helix and neutralize the phosphodiester backbone of DNA to 
induce progressive chromatin condensation (Marushige and Marushige, 1975). 
The protamine-DNA complex coils into concentric circles, which collapse onto 
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· each other. The proposed end result, in place of bulky histone solenoids is a 
highly condensed doughnut-shaped toroid (Hud et al., 1993) (Figure 1-3). 
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Figure 1-3. Nucleoprotein exchange and nuclear matrixloop domain model 
Adapted from Ward, 1993 
There are two processes involved in sperm chromatin condensation: 
phosphorylation-dephosphorylation of the serine and threonine residues of 
protamines and the formation of disulfide bonds between trie protamine cysteinyl 
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residues (Balhom et al., 1991; Green et al., 1994; Mayer, Jr. et al., 1981; Pfeifer 
et al., 2001; Ward and Coffey, 1991). Soon after their synthesis, protamines are 
highly phosphorylated; this is required for the correct positioning and binding of 
protamines to DNA (Green et al., 1994). Serine/arginine protein-specific kinase 1 
phosphorylates PRM1 (Papoutsopoulou et al., 1999). Calcium/calmodulin-
dependent kinase 4 (CAMK4) phosphorylates PRM2 and disruption of the Camk4 
gene results in male sterility, spermiogenesis impairment and abnormal sperm 
head morphology (Wu et al., 2000). Prior to spermiation or release of the sperm 
into the seminiferous tubule lumen and transfer to the epididymis, 
dephosphorylation of the protamines occurs, which precipitates chromatin 
condensation and stabilization (Oliva and Dixon, 1991); inter- and intra-molecular 
disulfide bonds form between adjacent thiol groups. The number of disulfide 
bonds created progressively increases as spermatozoa travel from the head 
(caput) to the tail (cauda) region of the epididymis during the maturation phase of 
germ cell development. These disulfide bonds have been shown to be created 
by the 34 kDa selenoprotein, glutathione peroxidase 4, also known as 
phospholipid hydroperoxide glutathione peroxidase. This enzyme, bound to 
sperm chromatin, uses the thiol groups of the protamines instead of glutathione 
and acts as a protamine thiol peroxidase rather than an antioxidant that reduces 
lipid peroxides (Conrad et al., 2005; Pfeifer et al., 2001). 
A higher order of organization exists in mammalian sperm nuclei in 
addition to protamine DNA condensation. Each doughnut-shaped toroid created 
represents oneDNA loop domain formed in association with the nuclear matrix; 
this is discussed in the following section. 
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1.1.2.2. The Nuclear Matrix 
Fort Y years ago, Don Fawcett first introduced the terrn "nuclear matrix" to 
describe the non-chromatin -structure of the nucleus (Fawcetl, 1966). The 
isolated, mainly proteinaceous, residual structure retains the ove ra Il shape and 
size of the nucleus (Berezney and Coffey, 1974). The original nuclear matrix 
isolation protocol, using nuclease and high salt concentrations, was developed by 
Berezneyand Coffey (1974) to extract the chromatin, histones and other soluble 
or loosely bound nuclear proteins from rat liver nuclei; however, many variations 
of the original protocol have been described depending on the cell type being 
used. Most isolation protocols include sequential treatments of isolated nuclei 
with ionic and non-ionic detergents, nucleases, and low and high ionic strength 
buffers (Martelli et al., 1996). The initial use of high ionic strength 2M NaCI to 
extract nuclear proteins greatly alters the appearance of the matrix, which may 
reflect selective removal of matrix components. The use of lower salt 
concentràtions, such as O.25M (NH4hS04, betler preserves the morphology 
without significantly affecting the efficacy of protein extraction (Belgrader et al., 
1991; Fey et al., 1986). 
The nuclear matrix consists of two domainS: an internai ribonucleic protein 
network and a peripheral lamina (Berezney and Coffey, 1974; Maraldi et al., 
1986). The internai nuclear matrix is composed of thick, polymorphie fibers, the 
composition of which is ce II-type specifie; it is constructed on an underlying three-
dimensional network of branched core filaments that connect to the nuclear 
lamina. Dense bodies resembling structural remnants of nucleoli are evident in 
this network. Ribonucleoproteins (RNPs) are atlached directly or indirectly to the 
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core filaments. RNA has been highlighted for its role in maintaining structural 
integrity; the inclusion of RNase inhibitors, vanadyl ribonucleoside complexes, 
results in the isolation of intact structures, whereas the use of Rnase A destroys 
the inner network, leaving behind nuclear shells (He et al., 1990; Nickerson et al., 
1989). The lamina is a continuous thin fibrous layer under the nuclear 
membrane, mainly composed of three proteins, lamin A, Band C, as weil as 
nucleokeratins (Franke, 1987; Gerace et al., 1984). Lamins are members of the 
intermediate filament protein family playing important roles in maintaining nuclear 
shape and controlling chromatin organization (Mattout et al., 2006). 
Similar to somatic cells, components exist in sperm that are resistant to 
solubilization. In the mouse sperm nucleus, a nuclear matrix has been described 
consisting of parts of a surrounding rigid perinuclear theca (PT) and a connected 
filamentous internai network. After the removal of protamines and DNA, the 
structure still retains the shape of the nutleus (Bellvé et al., 1992). In rodents, 
the PT surrounding the nucleus is composed of the subacrosomal perforatorium 
and postacrosomal sheath (Lalli and Clermont, 1981). During spermatogenesis a 
nuclear lamina as such does not appear to be present. The sperm nucleus either 
does not contain (Longo et al., 1987) or barely has detectable levels (Goldman et 
al., 1998; Schatten et al., 1985) of lamins A, Band C; in mouse sperm only lamin 
B is expressed beneath the PT in a punctuate pattern surrounding the nucleus 
(Moss et al., 1993). The PT resembles, in structure and perhaps function, the 
lamina of somatic cells even though it is located externally to the nuclear 
membrane. The protein constituents of the PT have not been completely 
defined. The perforatorium is composed of several proteins, the main one being 
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PERF 15 orfatty acid binding protein 9 in both mice and rats (Korley et al., 1997; 
Oko and Morales, 1994; Pouresmaeili etaI., 1997). The postacrosomal sheath 
contains actin capping proteins responsible for actin biogenesis and actin binding 
proteins (Howes et al., 2001; Hurst et al., 1998; Lecuyer et al., 2000; von Bulow 
et al., 1997); the main component is the keratin-like protein, calicin (Lecuyer et 
al., 2000; von Bulow et al., 1995). Bovine spermatozoa also contain somatic 
histones localized to the postacrosomal sheath (Aul and Oko, 2002; Tovich et al., 
2004; Tovich and Oko, 2003). 
Analysis of the mouse and human sperm internai nuclear matrix reveals 
scattered dense globular patches assembled on a network of thick and thin 
filaments. Immunoelectron microscope localization of RNPs during mouse 
spermatogenesis detects labeling only in primary spermatocytes up to elongating 
spermatids, concomitant with the cessation of RNA synthesis and the 
disappearance of nucleoli (Biggiogera et al., 1993; Biggiogera et al., 1994). In 
mature sperm nuclear vacuoles containing fibrils remain in place of nucleoli; 
interestingly, RNPs have been detected associated with vacuole fibrils (Sousa 
and Carvalheiro, 1994). Whether they play as great a role as in somatic cells is 
not clear. 
1.1.2.2.1. DNA Loop Domains and Gene Regulation 
The nuclear matrix in somatic cells has come under intense study over the 
last ten to fifteen years, as it is no longer considered to act just as structural 
support. Many studies revolve around the suggestion that the nuclear matrix may 
play a key role in genome organization and gene expression and have shown 
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that it is involved in many essential nuclear functions, including DNA replication 
and repair, transcription, and RNA processing and transport (Anachkova et al., 
2005; Mladenov et al., 2006; Mortillaro et al., 1996; van Driel et al., 1991). There 
are also indications as to a role of the matrix in nuclear signal transduction 
(Alessenko and Burlakova, 2002; Maraldi et al., 1992; Struchkov et al., 2002). 
The function of the sperm nuclear matrix is comparatively not as weil 
understood. As in the nucleus of somatic cells, chromatin within the male gamete 
is organized into loop domains (Klaus et al., 2001; Kramer and Krawetz, 1996; 
Nadel et al., 1995; Ward and Coffey, 1991), bound at the base in a non-random, 
sequence-specifie manner to the matrix (Kramer and Krawetz, 1996; Ward and 
Coffey, 1990) (Figure 1-3). These loops differ, however, with respect to their 
average size; loops within the sperm nucleus are .... 46 kb in size in hamsters 
(Ward et al., 1989) and .... 27 kb in humans (Barone et al., 1994), compared with 
.... 70 kb in other cell types (Vogelstein et al., 1980). Even during the early stages 
of spermatogenesis, the loop size decreases; it does not, however, change 
during spermiogenesis (Klaus et al., 2001). Adeninelthymine-rich matrix-
associated regions (MARs) anchor DNA loops to the matrix (Heng et al., 2004). 
These regions are either constitutive (for structural purposes) or transient 
(expression-related), with the latter depending on the functional state of the cell 
(Farache et al., 1990; larovaia et al., 2005; Razin, 1987). MARs delimit a domain 
considered to be an autonomously regulated unit within the genome. Somatic 
MARs are also common in or near origins of replication, introns, enhancers and 
transcription sites (Dijkwel and Hamlin, 1988; Gasser and Laemmli, 1986; 
Jarman and Higgs, 1988; Kalandadze et al., 1990). These regulatory sequences 
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relate to the domain-contained gene and regulatory elements act only within the 
boundaries of the domain. MARs permit regulatory elements to associate with 
each other on the matrix, thereby providing a platform for the assembly of protein 
machinery targeted to these specifie nuclear sites, such as replication and 
transcription factories, or those involved in chromatin modification and RNA 
spicing (Boulikas, 1994; Boulikas, 1995; Dworetzky et al., 1992). 
ln mature human sperm, analysis of a -40 kb region containing the genes 
for the sperm-specific Prm1, Prm2, and Tnp2, has shown that this region of the 
genome is demarcated by two MARs which attach it to the nuclear matrix along 
with other internai MARs which transiently associate with the matrix (Nelson and 
Krawetz, 1994). This subset of haploid-specific, as weil as other constitutively (a-
globin and p-actin) expressed genes, assumes an altered structural conformation 
as evidenced by their increased sensitivity to DNase 1 (Kramer and Krawetz, 
1996). Boundaries defined by MARs have been identified at the ends of DNase 
I-sensitive domains in numerous loci (Levy-Wilson and Fortier, 1989) and, 
correspondingly, transcriptionally active genes are found in these domains 
associated with the nuclear matrix (Ciejek et al., 1983). Interestingly, this 
haploid-specific region also contains ail the elements necessary for the correct 
spatial and temporal expression of this gene cluster (Choudhary et al., 1995). 
1.1.2.2.2. Protein Composition 
The nuclear matrix is a dynamic structure whose morphology and protein 
composition vary with the functional state of the nucleus (Penman, 1995). The 
use of two-dimensional gel electrophoresis to separate proteins based on their 
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isoelectric points (first dimension) and molecular weight (second dimension) has 
demonstrated that the protein profile of the matrix is exceptionally complicated, 
revealing several hundred polypeptides; specifie cell and tissue types can be 
identified by their nuclear matrix proteomic patterns (Fey and Penman, 1988; 
Getzenberg, 1994). The expression of several proteins change in differentiating 
cells (Zhao et al., 2006) and with neoplastic transformation (Getzenberg et al., 
1991). Changes also occur in the organization and general protein composition 
of the nuclear matrix in spermatocytes, round spermatids and elongating 
spermatids (Chen et al., 2001); protein expression appears to be either germ cell 
type-specifie or common to multiple germ cell types. Progressive and systematic 
changes in sperm matrix protein composition reflect the morphological and 
functional transitions occurring during spermatogenesis. 
Nakayasu and 8erezney (1991) have identified several abundant proteins 
that are ubiquitous in matrix preparations obtained from different somatic cells 
and tissues, the matrins. Other components include cell cycle regulators, tissue-
specifie transcription factors, RNA splicing factors, heterogeneous nuclear RNPs 
(hnRNPs), apoptotic proteins, tumor suppressor genes, phospholipases, protein 
kinases and many others. Residual components of the ribosome biogenesis 
center, the nucleolus, also make up part of the matrix; fibrillarin, C23/nucleolin 
and 823/nucleophosmin have been identified. 823/nucleophosmin, involved in 
RNA processing and transport and acting as a shuttle protein between the 
nucleus and cytoplasm, is one of the main constituents, along with RNPs (Martelli 
et al., 1996). Very little, however, is known about the components of the sperm 
nuclear matrix, especially since, unlike somatic cells, replication and transcription 
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do not occur in the mature sperm. To date, structural proteins, actin, myosin, 
and keratin, as weil as CAMK4 and the enzyme topoisomerase Il, have been 
identified in nuclear matrix fractions (Chen and Longo, 1996; Ocampo et al., 
2005; Wu and Means, 2000). CAMK4 has been implicated in transcriptional 
regulation and the histone-protamine exchange during spermiogenesis (Sun et 
al., 1995; Wu et al., 2000). Topoisomerase Il is an enzyme that catalyzes 
different DNA isomerization reactions, including DNA relaxation by double-strand 
breakage and rejoining mechanisms (Wang, 1985). It also plays a role in DNA 
replication and repair, transcription, as weil as the histone protamine exchange, 
and chromatin loop formation and atlachment to the nuclear matrix (Fernandes et 
al., 1995; Laberge and Boissonneault, 2005; Pu and Bezwoda, 2000; Wang, 
2002). The enzyme exhibits germ cell phase-specifie variations in expression up 
to the elongating spermatids, and maintains its activity in the matrix of 
spermatogenic cells (Chen and Longo, 1996). As a major component of both 
somatic and male germ cell matrices, topoisomerase Il may serve both catalytic 
and structural functions. 
Interestingly, phospholipids and their metabolizing enzymes are also 
components of nuclear matrices in numerous somatic cell types localized within 
the nucleolar remnant and inner filamentous matrix (Lubocka et al., 1995; Maraldi 
et al., 1992). Their presence has been reported to play both structural and 
functional roles; they represent specifie sites of DNA loop and RNP attachment to 
the nuclear matrix, and also regulate replication and transcription (Alessenko and 
Burlakova, 2002; Maraldi et al., 1992; Struchkov et al., 2002). Additionally, 
evidence accumulated over the past twenty years has highlighted the presence of 
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lipid-dependent nuclear signaling pathways (Alessenko and Burlakova, 2002; 
Maraldi et al., 1992; Martelli et al., 2002; Martelli et al., 2003). Both cell 
proliferation and differentiation are associated with defined metabolic changes of 
nuclear phospholipid components, which appear to be independent of 
phospholipids present in the rest of the Gall. In particular, phosphatidylinositol 
4,5-bisphosphate (PIP2), a key substrate for a number of important signaling 
proteins, has been identified in the nuclear matrix (Mazzotti et al., 1995). In 
addition to its role as a signal-generating lipid, PIP2 also binds to and regulates 
the function of actin-binding proteins (Fukami et al., 1992; Janmey and Stossel, 
1987; Lassing and Lindberg, 1985), and has the capability to reverse RNA 
transcription inhibition (Yu et al., 1998). During spermatogenesis, PIP2 is present 
at the nuclear level in ail cell types and specifically accumulates in the nuclei of 
late spermatids and spermatozoa (Caramelli et al., 1996); however, there is no 
evidence to show that this lipid is actually present in the nuclear matrix of the 
sperm. 
1.1.2.2.3. Nuclear Matrix Stability 
Given the complexity of sperm DNA structural organization, questions 
regarding its role in embryo development have arisen and research has focused 
on the stability of the sperm nuclear matrix with the thought that one factor 
associated with decreased fertility may be unstable matrices. Barone et al. 
(2000) developed the halo assay to assess nuclear matrix stability and have 
found unstable matrices in infertile cryptorchid patients. Even if sperm DNA is 
structurally intact, an unstable nuclear matrix will affect embryogenesis (Ward et 
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al., 1999); therefore, apart from the DNA itself, protein components of the matrix 
may be important. As in somatic cells, the attachment sites of DNA to the matrix 
may act as initiation sites for transcription and replication. DNA loop domain 
organization by the matrix may template the male genome for use following 
fertilization; alterations in structural organization may affect paternal genome 
expression and contribute to aberrations in early post-fertilization events, 
including protamine replacement by histones and pronuclear formation (Kramer 
and Krawetz, 1996). Controversially, Mohar et el (2002) suggest that ail the 
information needed for the construction of the paternal chromosomes in the 
zygote is contained within the sperm nuclear halos devoid of protamines and left 
with just chromatin attached to the nuclear matrix. Even in spermatozoa that 
appear normal, an unstable matrix would cause chromatin to be organized in 
such a way that normal functioning of the paternal DNA would be prevented and 
embryo development would not occur normally. 
1.2. Assessment of Sperm Quality and Function 
A variety of tests have been and continue to be developed in clinical 
andrology to examine spermatozoa and to assess individual fertility potential, and 
in reproductive toxicology to monitor effects from chemical exposures. 
Conventional semen analysis measures parameters such as sperm cou nt, 
motility, and morphology. The World Health Organization (WHO, 1999) has 
established threshold values of specific sperm parameters associated with the 
fertilizing potential of normal human semen (Table 1-1). Many of these attributes 
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are measured with greater ease since the development of computer assisted 
semen analysis (CASA). 
Table 1-1. World Health Organization threshold values for normal semen parameters 
Volume 
Sperm concentration 
Total sperm count 
Morphology 
Motility 
Sperm viability 
PH 
~2ml 
~ 20 million/ml 
~ 40 million per ejaculate 
~ 30% normal 
~ 50% motile 
~ 75% viable 
7.2-7.8 
Going beyond these basic sperm parameters, a variety of assays have 
been developed to monitor sperm function and to predict their fertilizing capacity, 
including sperm cervical mucus penetration, capacitation, zona recognition, 
acrosome reaction, sperm-egg fusion, and in vitro egg penetration (Aitken, 2006). 
Using flow cytometry, multiple sperm features are now rapidly measured 
simultaneously on an individual cell basis; these include sperm viability and 
mitochondrial function (Gravance et al., 2001). Numerous fluorescent staining 
techniques have been developed for the evaluation of specifie sperm 
characteristics and functions, including plasma membrane integrity (Gillan et al., 
2005). Hypo-osmotic swelling is also performed to assess sperm membrane 
structural integrity (Oosterhuis et al., 1996). 
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With the abundance of available tests, what was lacking was the 
assessment of nuclear DNA integrity. Some men with normal sperm 
measurements, such as sperm count and motility, may have defects within the 
nucleus which would not be detected with the tests originally used for sperm 
assessment. A research area that has been studied intensely during the past 
decade is DNA integrity in mature spermatozoa and more recently, chromosome 
organization defects. Fertilization with DNA-damaged spermatozoa could lead to 
paternal transmission of defective genetic material with adverse consequences 
on embryonic development (Ahmadi and Ng, 1999; Alvarez et al., 2004; Harrouk 
et al., 2000a; Lewis and Aitken, 2005). The advantage of the development of 
assays to address this issue, compared to the aforementioQed tests, is that they 
not only yield information on the fertilizing capacity of spermatozoa, but also on 
their ability to support normal embryonic development. Sorne of the currently 
available tests evaluate the integrity of sperm DNA and chromatin structure 
(Table 1-2). The cornet assay measures DNA fragmentation (single and double-
strand breaks) in individual sperm nuclei based upon gel electrophoretic patterns 
(Tice et al., 2000). The sperm chromatin structure assay (SCSA) measures 
abnormal chromatin structure based on the susceptibility of sperm nuclear DNA 
to acid-induced denaturation in situ; a review of data on hundreds of semen 
samples shows that patients with a DNA fragmentation index greater than 30% 
are likely to have significantly-reduced fertility potential as weil as a greater risk of 
embryo loss (Virro et al., 2004). Other techniques which also identify sperm 
chromatin packaging defects include: 1) aniline blue staining that reveals 
differences in the basic nuclear protein composition. This dye positively stains 
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sperm when bound to lysine; immature spermatozoa that are rich in histones are 
also rich in lysine; 2) toluidine blue staining, which binds to chromatin and 
therefore becomes heavily incorporated in poorly packaged sperm; 3) 
monobromobimane staining, which binds to reactive protamine thiol groups; 
poorly condensed and stabilized chromatin is positively stained; and 4) 
chromomycin A3 staining, which indirectly reveals protamine- deficient chromatin 
(Agarwal and Allamaneni, 2005; Agarwal and Said, 2004). 
Table 1-2. Methods to assess sperm DNA and chromatin structure integrity 
Parameter measured 
DNA denaturation 
DNA fragmentation 
Technique 
SCSA 
Acridine orange 
Cornet (neutral - DSB) 
(alkaline - SSB/DSB) 
ln situ nick translation (SSB) 
TUNEL 
DBD-FISH (SSB) 
Sperm chromatin dispersion 
Oxidative DNA damage 8-0HdG DNA adduct assay 
Chromatin packaging Chromomycin A3 (DNA protein composition) 
Aniline blue (DNA protein composition) 
MBBr (Thiol-disulfide status) 
Toluidine blue 
8-0HdG, 8-hydroxy-2-deoxyguanosine; OBO-FISH, ONA breakage detection-
fluorescent in situ hybridization; TUNEL, terminal deoxynucleotidyl transferase-
mediated deoxyuridine triphosphate nick end labeling; OSB, double strand break; 
SSB, single strand break. 
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Chromatin abnormalities in sperm could present as 
condensation/packaging defects, ONA breaks, or chromosomal aneuploidies and 
as discussed above, various tests have been developed to target these 
chromatin abnormalities; the cause of such anomalies could be exposure to a 
variety of environmental, occupational, recreational or therapeutic compounds 
that have the potential to affect male germ cells. 
1.3. Male-Mediated Developmental Toxicity 
1.3.1. Toxicant Exposure and Male Germ Cells 
Investigation into the mechanisms of action of the pesticide, 
dibromochloropropane (OSCP) as a testicular toxicant prompted great interest in 
the effects of environmental and occupational chemicals on male reproductive 
health. OSCP is the classical compound that indisputably impairs fertility in 
males; exposure causes reduced sperm counts characterized as 
oligozoospermia, or partial reduction in sperm numbers, and azoospermia, which 
is the complete absence of sperm (Whorton et al., 1977; Whorton et al., 1979). 
Epidemiological studies suggest that paternal occupations, such as welding, auto 
mechanics, painting, farming, and firefighting that expose men to certain 
chemicals may be associated with adverse reproductive outcomes, including 
spontaneous abortions, birth defects, low birth weight and childhood cancer (Chia 
and Shi, 2002; Savitz, 1994). Exposure to pesticides other than OSCP correlates 
with altered morphology, decreased sperm counts, sperm aneuploidy and altered 
sperm chromatin structure (Harkonen, 2005; Kumar, 2004; Sanchez-Pena et al., 
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2004). Other industrial chemicals associated with reproductive dysfunction in 
human males include lead, mercury, ethylene glycol ethers, carbon disulfide and 
ethylene dibromide (Lan cran jan et al., 1975; Schrag and Dixon, 1985; Winker 
and Rudiger, 2006). For thousands of other chemicals, the association between 
exposure and male reproductive dysfunction is only suspected and requires 
further evaluation before conclusions can be drawn. 
There are a number of chemicals to which men may be exposed based on 
their lifestyle, such as alcohol, caffeine, cigarettes, and iIIicit drugs, yet 
inadequate epidemiological or toxicological evidence exists to clearly and 
definitively indicate effects on reproductive function or progeny outcome. 
Cigarette smoke may be the only exception, as some evidence suggests that 
there is an association with increased risk for sperm aneuploidy (Robbins, 2003; 
Rubes et al., 1998), along with decreased sperm counts, abnormal morphology, 
and oxidative DNA damage (Robbins, 2003). Exposure to testicular toxicants 
most often involves complex mixtures of hazardous chemicals; some contain 
many active ingredients, making it challenging to identify which agent is 
responsible for toxic effects and to draw any decisive conclusions about the 
consequences on progeny. 
Cancer patients treated with chemotherapy or radiation provide a 
considerable amount of information on the effects of male preconceptional 
exposure to toxicants on human reproduction. Chemotherapeutic agents have 
been shown to be gonadotoxic in a dose-dependent and time-specific manner, 
rendering a proportion of cancer survivors with persistent oligozoospermia or 
azoospermia (Magelssen et al., 2006). Germinal cell genetic damage has also 
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been shown in men undergoing cytotoxic therapy (Chatterjee et al., 2000; 
Robbins et al., 1997); damaged sperm are still capable of fertilization (Ahmadi 
and Ng, 1999). Presently, however, there are no data that show any increase in 
the incidence of birth defects or genetic disease in the children of cancer 
survivors (Byrne et al., 1988; Green and Hall, 1988; Nygaard et al., 1991). One 
must keep in mind that epidemiological evidence is clouded by the fact that the 
number of patients followed in most studies is low and therefore it is difficult to 
assess the impact of cancer treatment on the offspring of exposed men. 
1.3.2. Male Germ Cell Susceptibility 
Contrary to the limitations of human studies, animal studies offer the 
advantage of defining the chemical, dose and duration; specifie windows of 
toxicant exposure can be assessed to deduce the susceptibility of specifie germ 
cell types to potential developmental toxicants and to elucidate the mechanisms 
of action of gonadotoxicants during spermatogenesis. Knowledge of the kinetics 
of spermatogenesis allows one to ascertain germ ce II-specifie susceptibilities by 
timing toxicant exposure; by calculating back from the time of sperm collection or 
mating, it is possible to determine which germ cell type was affected and 
responsible for effects observed later in the sperm (diminished quantity and/or 
quality) or progeny (pre- and post-implantation loss, and congenital and 
behavioural malformations) (Adler, 2000; Clermont, 1972; Russell, 1994). Table 
1-3 shows the germ cell types first exposed to an administered toxicant 
depending on the time between initial exposure and mating or sperm collection in 
the rat. 
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Table 1-3. Time of toxicant exposure and the germ cell type first exposed in rats 
Time of exposure 
(weeks) 
1 
2 
3 
4 
5-7 
8+ 
Germ cell type first exposed 
Epididymal spermatozoa 
Late elongated spermatids 
Mid elongating spermatids 
Early round spermatids 
Spermatocytes 
Spermatogonia 
The differential susceptibility of germ cells to certain toxic compounds has 
been identified. For example, bleomycin and procarbazine induce specific locus 
mutations in spermatogonial stem cells of mice (Russell et al., 2000; Witt and 
Bishop, 1996). These cells are also particularly susceptible to X-ray exposure in 
both mice and men (Clifton and Bremner, 1983). Mitomycin C exerts its effects 
primarily on spermatocytes (Adler et al., 1996). Chlorambucil and melphalan also 
have reproductive effects attributable to cytotoxicity in specific male germ cell 
types; both induce dominant lethal mutations and heritable translocations in post-
meiotic germ cells, particularly in early to mid spermatids (Generoso et al., 1995). 
As for epididymal spermatozoa, it has been shown that they are maximally 
sensitive to acrylamide and ethylnitrosourea, which induce specific locus 
mutations and dominant lethality (embryo death), respectively (Russell, 1994). 
Certain agents, such as methyl methanesulfonate and acrylamide, alkylate the 
cysteine sulfhydrl groups of sperm protamines (Sega et al., 1989; Sega and 
Owens, 1983). Interestingly, the primary mechanism causing dominant lethality 
30 
has been proposed to be inhibition of normal chromatin condensation in late 
spermatids and early spermatozoa, which would render chromosomes at risk of 
breakage (Sega, 1991; Sega and Owens, 1983). 
Animal studies have provided clear evidence that paternal exposure to 
cancer therapeutic agents induces adverse effects on progeny outcome 
(Brinkworlh and Nieschlag, 2000; Robaire and Hales, 2003; Russell, 1994; 
Trasler and Doerksen, 1999). The most widely studied male-mediated 
developmental toxicant is the commonly used anti-cancer drug, 
cyclophosphamide. 
1.4. Cyclophosphamide 
Clinically used for over forly years, cyclophosphamide is a bifunctional 
alkylating agent related to nitrogen mustard. It is used extensively in acute 
regimens for childhood (Kenney et al., 2001; Thomson et al., 2002) and adult 
malignancies (Colvin, 1999), including breast, ovarian and lung cancer, as weil as 
Hodgkin's and non-Hodgkin's Iymphoma, and acute and chronic Iymphocytic 
leukemia. The drug, in chronic regimens is also an immunosuppressant for 
disorders such as systemic lupus erythematosus, Wegener's granulomatosis, 
rheumatoid arlhritis, and graft-versus-host disease (Colvin, 1999). 
Cyclophosphamide requires hepatic metabolic activation in order to be 
effective; cytochrome P450 enzymes transform cyclophosphamide into 4-
hydroxycyclophosphamide (4-0HCP), the main active metabolite. 4-0HCP 
interconverls with its tautomer, aldophosphamide and both of these metabolites 
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diffuse out of hepatic cells, circulate, and enter other cells. Aldophosphamide is 
oxidized to form the inactive metabolite carboxyphosphamide by aldehyde 
reductase (ALDH), or it undergoes a spontaneous elimination reaction to form 
phosphoramide mustard and acrolein (Boddy and Yule, 2000; Fleming, 1997) 
(Figure 1-4). Phosphoramide mustard is a bifunctional alkylating agent with two 
reactive chloroethyl side chains capable of forming covalent bonds with 
nucleophilic sites on DNA or protein, such as the N-7 position of guanine, 
resulting in inter- and intra-strand DNA cross-links, DNA-protein cross links and 
DNA strand breaks (Anderson et al., 1995). Cross-lin king inhibits DNA 
transcription and replication, thereby preventing cancerous cells from multiplying 
and causing cell death. Acrolein also alkylates DNA and proteins to exert 
cytotoxic effects (Crook et al., 1986). It is primarily responsible for bladder 
toxicity leading to hemorrhagic cystitis (Fraiser et al., 1991). 
Cyclophosphamide 4-OHCP Aldophosphamide l ALDH 
Carboxyphosphamide 
Figure 1-4. Cyclophosphamide metabolism 
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1.4.1. Cyclophosphamide as a Male-Mediated Developmental Toxicant 
Numerous reports indicate that treatment with acute high doses or chronic 
low doses of cyclophosphamide alters male fertility, resulting in oligozoospermia 
or azoo~permia in adults (Fairley et al., 1972; Qureshi et al., 1972). Animal 
experiments have been and continue to be done to elucidate how 
cyclophosphamide affects the male germ cell and the impact this has on embryo 
development (Anderson et al., 1995; Robaire et al., 2006; Trasler et al., 1985; 
Trasler et al., 1986; Trasler et al., 1987). Different germ ce Il types 
(spermatogonia, spermatocytes, spermatids and epididymal spermatozoa) are 
clearly differentially sensitive to cyclophosphamide and the effects on progeny 
outcome (different rates of preimplantaion loss, postimplantation loss and 
congenital malformations) are dependent on the phase of spermatogenesis when 
germ cells were tirst exposed to the drug (Trasler et al., 1986; Trasler et al., 
1987). 
The exposure to cyclophosphamide throughout germ cell development 
and maturation i.e. from spermatogonia to spermatozoa, results,in an increased 
incidence of growth retardation and malformations, including hydrocephaly, 
edema and micrognathia (Trasler et al., 1986); these malformations are also 
observed in the F2 generation (Hales et al., 1992). Chromosomal aberrations 
could be involved in mechanisms leading to potentially heritable defects; 
spermatogonia, however, have been reported to be at low risk for the induction of 
heritable translocations by cyclophosphamide (Generoso et al., 1981; Sotomayor 
and Cumming, 1975). Interestingly, other chromosomal abnormalities associated 
with spermatogonial exposure to cyclophosphamide have been reported. 
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Significant increases in the frequency of spermatozoa with chromosome 4 
disomy (Y44) and nullisomy (YO) are associated with germ cell drug exposure 
initiated during mitosis (9 weeks) though not during meiosis· (6 weeks), 
suggesting that cyclophosphamide disrupts meiotic events before they begin 
(Barton et al., 2003). 
Interestingly, chronic exposure to low doses of cyclophosphamide during 
mitosis leads to significant levels of DNA damage in spermatocytes; however, it 
does not impair meiotic progression (Aguilar-Mahecha et al., 2005). Only acute 
exposures increase DNA damage in spermatocytes and impair meiotic 
progression (Aguilar-Mahecha et al., 2005), along with the induction of gene 
conVersions and mutations (Schimenti et al., 1997; Zhang et al., 2002), 
synaptonemal complex damage (Allen et al., 1988; Backer et al., 1988) and 
micronuclei formation (Lahdetie, 1983). Correspondingly, chronic administration 
of cyclophosphamide, targeting germ cells first exposed to the drug as 
spermatocytes, results in increased preimplantation loss (Trasler et al., 1986; 
Trasler et al., 1987). Ali things considered, these results signify a defect in germ 
cell DNA checkpoint mechanisms after repeat exposure to low doses of a 
genotoxic agent, allowing damage to be transmitled throughout spermatogenesis. 
ln fa ct , reduced ability to respond to stress wasevident, as chronic low dose 
treatment dramatically decreased the expression of stress response genes 
(oxidative stress-related, heat shock and DNA repair) in pachytene 
spermatocytes and round spermatids (Aguilar-Mahecha et al., 2002). 
Post-meiotic germ cells are the most susceptible to cyclophosphamide 
effects (Ehling and Neuhauser-Klaus, 1988; Generoso et al., 1981; Sotomayor 
34 
and Cumming, 1975). This may be partly due to their inability to repair DNA or to 
undergo apoptosis, thus resulting in an accumulation of damage in spermatozoa; 
studies show that late spermiogenic germ cells have lost many of the enzymes 
associated with DNA repair (Sotomayor et al., 1978) and drug-induced apoptosis 
was most prominent in spermatogonia and spermatocytes (Brinkworth and 
Nieschlag, 2000; Cai et al., 1997; Sinha Hikim and Swerdloff, 1999). Using the 
alkaline elution assay, overall assessment of DNA damage in male germ cells 
after cyclophosphamide administration revealed an increase in DNA single-strand 
breaks one week post-treatment (Qiu et al., 1995a), whereas cyclophosphamide 
given for six weeks significantly increased DNA single-strand breaks as weil as 
DNA-DNA cross-links in spermatozoa of drug-exposed rats (Qiu et al., 1995a); 
the duration of this treatment exposes germ cells from the meiotic phase 
throughout spermiogenesis and epididymal spermatozoa maturation. The 
exposure of either epididymal spermatozoa or testicular spermatids to 
cyclophosphamide results in an adverse effect on progeny outcome; primarily, 
dose-dependent increases in post-implantation loss occur (Qiu et al., 1992; 
Trasler et al., 1986). In particular, there are time specifie inereases in post-
implantation loss associated with the phase of spermiogenesis exposed to the 
drug; a progressive increase in postimplantation loss started at 2 weeks, reaehing 
to about 75% post-implantation loss by 4 weeks. Interestingly, this effect is 
reversed within 4 weeks post-treatment (Hales and Robaire, 1990), thus 
highlighting the importance of spermiogenic chromatin remodeling and sperm 
maturation on the suceess of embryo development. 
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1.5. Rationale and Formulation of the Question 
Infertility is the failure to achieve a pregnancy after regular unprotected 
intercourse for at least one year or to carry a pregnancy to full term. Adverse 
reproductive outcomes include diverse endpoints such as early pregnancy loss or 
spontaneous abortions, stillbirths and preterm delivery, as weil as growth 
retardation and congenital malformations. Approximately 15% of couples are 
infertile (Evers, 2002) with at least 50% of ail conceptions estimated to result in 
fetal loss before the end of the first trimester (Goldstein, 1994; Wilcox et al., 
1999). In about 40% of cases male infertility is the primary cause or contributing 
factor (Centers for disease control and prevention' (COC), 2003). The 
consequences of exposure of males to drugs, radiation and environmental 
toxicants on reproduction and development are a growing concern as it becomes 
increasingly clear that exposure to such toxicants impairs sperm quality; the 
mechanisms involved, however, are not as evident. 
To date, assisted reproductive technology, in particular intracytoplasmic 
sperm injection (ICSI) is the only effective treatment for most cases of male 
infertility. ICSI, first introduced to help oligozoospermic men to become fathers 
(Palermo et al., 1992), quickly became a technique to achieve pregnancies in 
couples with extreme male factor infertility, using sub-optimal immature sperm 
from the epididymis (Oevroey et al., 1995; Schlegel et al., 1995), and testis 
(Bourne et al., 1995; Silber et al., 1995), as weil as injecting spermatids (Fishel et 
al., 1995; Tesarik et al., 1995) or sperm with abnormal morphology (Harari et al., 
1995; Rybouchkin et al., 1997) into eggs. Whether fertilization occurs naturally or 
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with assistance, there are valid concerns about the consequences to the progeny 
if male germ cells are altered or defective. 
Chromatin abnormalities in male germ cells pose a risk to the offspring if 
transmitted to the developing embryo; either spontaneous abortion and/or 
congenital malformations may result. Increasing evidence suggests that these 
risks are high in embryos generated from assisted reproductive techniques 
(Bonduelle et al., 1999; Hansen et al., 2002). There are multiple mechanisms by 
which xenobiotics may induce adverse embryo outcomes. A few which have 
been proposed are: 1) direct effects on chromosomes (aneuploidy or 
clastogenicity) or genes; 2) epigenetic effects affecting gene expression; and 3) 
indirect effects on chromosomes or genes, via alteration of DNA repair capacity 
or sperm chromatin packaging/condensation (Ratcliffe, 1994). 
Functional maternai and paternal genomes are fundamental to the 
complex events involved in early embryogenesis. Changes in the DNA of either 
parent as a result of toxicant exposure may lead to changes in the progression 
and coordination of development. Previous studies of parental contributions to 
embryonic development indicate that absence of the paternal genome results in 
aberrant development (Barton et al., 1984; McGrath and Solter, 1984). To 
ensure the genetic integrity of the zygote and the success of ensuing embryonic 
development there are essential features required that include, in addition to 
oocyte-specific events, the exchange of proteins in the sperm nucleus (protamine 
to histones) and remodeling of the sperm nucleus into a functional pronucleus. 
Transcriptional activation of specifie genes is initiated after fertilization and 
remodeling of the sperm chromatin after fertilization is fundamental for the 
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expression of the paternal genome (Schultz, 2002). Above ail, gene expression 
is regulated by chromatin structure (Schultz and Worrad, 1995), thus the sperm 
chromatin structure is key to ensure that embryogenesis proceeds normally. The 
unique structure of sperm chromatin depends on a sequence of events that 
involves the expression of numerous proteins, precise organization of the DNA 
and condensation of the chromatin during spermiogenesis. Any perturbations to 
the integrity of sperm DNA or structure could be detrimental; in fact, a significant 
association between male subfertility and abnormal nuclear condensation has 
beensuggested (Hammadeh et al., 1999) . 
. Cyclophosphamide is widely used as a model drug to ascertain the 
molecular mechanisms underlying the developmental toxicity induced following 
paternal exposure. Spermatids and spermatozoa do not have the ability to repair 
DNA or undergo apoptosis, rendering them most susceptible to genotoxic 
damage; the refore , any insult incurred remains. Consequently, DNA damage 
found in cyclophosphamide-exposed spermatozoa is imparted to the newly 
fertilized zygote (Harrouk et al., 2000a). As weil, decondensation of drug-
exposed spermatozoa is disturbed; sperm decondense more rapidly than control 
spermatozoa in denuded hamster oocytes and male pronuclear formation is 
earlier in rat oocytes sired by drug-treated males (Harrouk et al., 2000b; Qiu et 
al., 1995b). Cyclophosphamide damages male germ cells in such a way that 
altered zygotic gene activation and embryo death result (Robaire et al., 2006). 
The aforementioned evidence suggests that altered sperm chromatin remodeling 
may be a factor in the effects of cyclophosphamide on progeny outcome. 
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Therefore, 1 focused the studies in this thesis on the spermiogenic and 
maturation events of post-meiotic male germ cells and the effects of 
cyclophosphamide on the cells during this time. The hypothesis of this thesis is 
that: Cyclophosphamide exposure causes genetic damage and alters the 
sperm proteome, thus disrupting components of chromatin condensation 
and organization during the spermiogenic phase of spermatogenesis. 
To address this hypothesis, 1 set forth the following objectives: 
1. Assess the phase specificity of the susceptibility of spermiogenic germ 
cells to genetic damage induced by cyclophosphamide. 
2. Assess the effects of cyclophosphamide on the sperm chromatin structure 
and basic proteome. 
3. Analyze the effect of cyclophosphamide exposure on the protein profile of 
the sperm nuclear matrix. 
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Connecting Text 
Chronic cyclophosphamide dosing regimens targeting post-meiotic germ 
cells result in increased drug-induced DNA damage, as weil as time-specific 
increases in adverse progeny outcomes. Of interest is whether spermiogenic 
germ cells are differentially susceptible to damage, therefore accounting for the 
time-specific effects observed. We used the cornet assay to determine among 
the different types of spermatids, if the extent of DNA damage incurred depends 
on when during spermiogenesis spermatids acquire damage. The first study was 
designed using acute, subchronic and chronic dosing regimens with 
cyclophosphamide to assess spermiogenic germ cell phase-specifie DNA 
damage. 
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2.1 ABSTRACT 
The production of genetically competent spermatozoa is essential for 
normal embryo development. The chemotherapeutic drug cyclophosphamide 
creates cross-links and DNA strand breaks in many ceU types, including germ 
cells. This study assessed the phase specificity of the susceptibility of 
spermiogenic germ cells to genetic damage induced by cyclophosphamide. Adult 
male rats were given cyclophosphamide using one of four schedules: 1) high 
dose/acute- day 1,100 mg/kg; 2) low dose/subchronic, 4 days-days 1--4, 6.0 
mg/kg/d; 3) high dose/subchronic, 4 days-day 1, 100 mg/kg, and days 2--4, 50 
mg/kg/d; and 4) low dose/chronic-daily, 6.0 mg/kg/d for 14-28 days. To capture 
cauda epididymal spermatozoa exposed to cyclophosphamide during late, mid-, 
and early spermiogenesis, animais were sacrificed on days 14, 21, and 28, 
respectively. Spermatozoa were analyzed for DNA strand breaks using the cornet 
assay. No dramatic increases in damage were seen after high-dose/acute 
exposure to cyclophosphamide. Subchronic exposure showed a dose-related 
increase in DNA damage; maximal damage, as demonstrated by cornet tail 
parameters, was seen after 21 days, reflecting an increased susceptibility of step 
9-14 spermatids. Low-dose chronic exposure to cyclophosphamide induced DNA 
damage, which reached a plateau by day 21. The magnitude of damage at ail 
time points after low-dose chronic exposure was much greater than that following 
low-dose exposure for 4 days, indicating an accumulation of damage over time. 
Thus, the DNA damage induced by cyclophosphamide is germ cell phase-
specific. The most damaging effects of cyclophosphamide occurred during a key 
point of sperm chromatin remodeling (histone hyperacetylation and transition 
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protein deposition). We speculate that strand breaks disrupt chromatin 
remodeling, hence affecting chromatin structure and embryo development. 
2.2 INTRODUCTION 
Society has growing concerns about the consequences of exposure to 
drugs and toxicants on the reproductive system, germ ceUs, fertilization, and 
development. Preconceptional exposure to drugs, radiation, or chemicals results 
in embryo loss, birth defects, and predisposition to cancer (Dlshan and Matlison, 
1994; Brinkworth, 2000; Robaire and Hales, 2003). Paternal exposure to toxicants 
may cause changes in sperm quality, thereby contributing to infertility and 
adverse progeny outcomes. Evidenceis now accumulating about the importance 
to embryogenesis of genetically competent spermatozoa during both natural and 
assisted fertilization. Several authors have reported significant correlations 
between sperm DNA damage and effects on fertilization as weil as embryo 
cleavage and pregnancy rates (Sun et al, 1997; Lopes et al, 1998b; Larson et al, 
2000; Morris et al, 2002). 
Among the commonly used anticancer drugs, alkylating agents have been 
associated most often with the development of infertility (Schilsky, 1980; Pont, 
1997). Cyclophosphamide is a cytotoxic alkylating agent widely used in 
chemotherapeutic regimens. Its cytotoxic effects are the result of chemically 
reactive metabolites that create DNA adducts, DNA-DNA and DNA-protein 
crosslinks, sister chromatid exchanges, chromosomal aberrations, and DNA 
strand breaks (Sotomayor and Cumming, 1975; Bishop et al, 1997). Exposure of 
male germ ceUs to cyclophosphamide leads to single-strand breaks, crosslinks, 
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and altered in vitro spermatozoal decondensation and template function (Qiu et 
al, 1995a,b). With little effect on the male reproductive system, chronic paternal 
treatment of rats with cyclophosphamide results in increases in embryo death and 
growth-retarded and malformed fetuses (Trasler et al, 1985, 1986, 1987; 
Jenkinson and Anderson, 1990). Although proliferating premeiotic germ cells are 
sensitive to alkylating agents, nondividing postmeiotic spermatids and 
spermatozoa are the most susceptible to DNA damage, leading to dominant 
lethality, heritable translocations, specifie locus mutations, and malformations 
(Jackson, 1964; Ehling et al, 1968). Certain monofunctional alkylating agents, 
such as methyl methanesulfonate and ethylene oxide, produce more dominant 
lethal mutations and translocations in late spermatids and early spermatozoa than 
in any other germ cell stage (Ehling, 1980; Generoso et al, 1980). In contrast, 
other chemicals, such as eth yi nitrosourea and methyl nitrosourea, show no germ 
cell stage-specific selection, with a wide range of effects on both pre- and 
postmeiotic germ cells (Russell et al, 1979; Sega et al, 1981). Cross-linking 
agents are also active throughout spermatogenesis; however, maximal genetic 
damage has been observed in early round spermatids (Russell, 1989, 1992). 
Dramatic increases inpostimplantation loss are dose-dependent and maximal 
after a 3-week treatment of male rats with a low dose of cyclophosphamide 
(Trasler et al, 1985, 1986, 1987), which thereby exposes germ cells during 
spermiogenesis and sperm maturation. 
Abnormal sperm chromatin packaging, identified as poorly protaminated 
spermatozoa or a high susceptibility of DNA to acid-induced denaturation using 
the sperm chromatin structure assay, has been correlated with the presence of 
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DNA strand breaks (Gorczyca et al, 1993; Manicardi et al, 1995, 1998; Sai 1er et 
al, 1995). Mature spermatozoa contain highly packaged chromatin organized in a 
specific manner to allow access to required genetic information during 
embryogenesis. The proposed model for sperm DNA packaging consists of 
several levels of organization, including DNA loop domains attached to the 
nuclear matrix in a sequence-specific manner (Ward and Coffey, 1991; Ward, 
1993) and protamine DNA binding (Balhom, 1982). With such an intricate 
organization of the sperm nucleus, the possibility exists that damage to the DNA 
will, in tum, affect overall nuclear organization. Continuous treatment with 
cyclophosphamide for 4 weeks targets the male germ cell through ail stages of 
spermiogenesis and sperm maturation. The adverse progeny outcomes 
associated with patemal exposure to this drug may be due to the accumulation of 
DNA damage in male germ ce Ils as round spermatids develop into spermatozoa 
or due to spermiogenic germ cell phase-specific susceptibility to damage. 
Genotoxic damage in the form of single- and double-stranded breaks can 
be measured using the cornet assay. This assay is used extensively to assess 
DNA damage in somatic cells and has been applied to human and murine 
spermatozoa (Singh et al, 1989; Haines et al, 1998; Tice et al, 2000). Increased 
DNA damage in human spermatozoa measured by the cornet assay is associated 
with infertility (Irvine et al, 2000) and exposure to chemotherapeutic agents 
(Chatterjee et al, 2000). In this study, we have developed the cornet assay under 
alkaline conditions for rodent spermatozoa. We have used this assay to 
determine to what extent and at which point during spermiogenesis sperm acquire 
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DNA damage after acute, subchronic, and chronic dosing regimens with 
cyclophosphamide. 
2.3 MATE RIALS AND METHODs 
Animal Treatments 
Adult male Sprague-Dawley rats (400-450 g) were obtained from Charles 
River Canada (St Constant, Canada), maintained on a 14:10 light-dark cycle, and 
provided with food and water ad libitum. Rats were gavaged with saline or 
cyclophosphamide (CAS 6055-19-2; Sigma-Aldrich, Oakville, Canada) using one 
offour schedules: 1) high dose/acute-day 1, 100 mg/kg; 2) low dose/subchronic, 
4 days-days 1-4, 6.0 mg/kg/d; 3) high dose/subchronic, 4 days-day 1, 100 
mg/kg, and days 2-4,50 mg/kg/d; and 4) low dose/chronic-daily, 6.0 mg/kg/d for 
14-28 days. To capture spermatozoa tirst exposed to cyclophosphamide during 
late, mid-, and early spermiogenesis, animais were sacrificed by decapitation on 
days 14, 21, and 28 after the initiation of treatment (Clermont, 1972). Animal 
handling and care were performed in accordance with the guidelines established 
by the Canadian Council on Animal Care. 
Sperm Collection 
To isolate spermatozoa from the cauda epididymides, the epididymides were first 
removed, trimmed free of fat, and washed in 2 ml of prewarmed (37°C) 10 mM 
Tris-HCI buffer containing 50 mM NaCI and 50 mM EGTA, pH 8.2-8.4. This 
medium maintains the genetic integrity of frozen spermatozoa (Kusakabe et al, 
2001). The corpus-cauda epididymal junction was then clamped with a hemostat, 
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and an incision was made in the distal cauda epididymidis. Spermatozoa 
released from the site of incision were collected in 2 ml of media at 3rC, 
incubated for 5 minutes to allow the spermatozoa to disperse, and then diluted 
1: 1 0 in fresh media. Aliquots of 100 JJl were stored at -80°C until comet analysis 
was performed. 
Detection of Damage in Individual Gells Using the Gomet Assay 
DNA damage in spermatozoa was evaluated using the comet assay as 
previously described (Singh et al, 1989; Haines et al, 1998) with the following 
modifications. Frozen sperm samples were thawed on ice and resuspended in 
Tris-HCI-buffered EGTA medium to a concentration of 1 x 105 ceUs/mL. Fifty 
microliters of the cell suspension was added to 500 JJl of molten aga rose (0.5% 
low-melting-point grade in Mg2+ and Ca2+-free phosphate-buffered saline, pH 
7.4, at 42°C). Sixt Y microliters was immediately pipetted and evenly spread onto 
slides (Trevigen Inc, Gaithersburg, Md), and the gel was allowed to solidify at 4°C 
in the dark for 10 minutes. Ali subsequent steps were performed under yellow 
light or in the dark to prevent any additional DNA damage. 
Siides were immersed in prechilled (4°C) Iysis buffer (2.5 M NaCI, 100 mM 
EDTA, and 10 mM Tris-HCI; final pH, 10) containing 10% dimethylsulfoxide, 1% 
Triton X-100, and 40 mM dithiothreitol for 1 hour on ice. Following initial Iysis, 
slides were washed in distilled water for 5 minutes. Proteinase K, at a 
concentration of 0.1 mg/ml, was added to fresh prewarmed Iysis buffer, and 
additionallysis was performed for 3 hours at 3rC. Siides were washed in distilled 
water, placed fiat at 4°C for 10 minutes to reset the agarose, and then immersed 
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in freshly prepared alkaline solution (1 mM EDTA and 0.05 M NaOH, pH 12.1)for 
45 minutes in the dark. Siides were washed twice in 1 x Tris-Borate-EDTA buffer 
, (TBE, pH 7.4) for 5 minutes and th en placed equidistant from the electrodes on a 
gel tray submerged in TBE in a horizontal electrophoresis apparatus (Mini-Sub 
Cell GT; Bio-Rad Laboratories, Inc, Mississauga, Canada). The level of TBE was 
2-4 mm above the slides. Electrophoresis was carried out at 14 V (0.7 V/cm) for 
10 minutes. Siides were drained and fixed in ice-cold 70% ethanol for 5 minutes 
and left to air dry prior to storage with desiccant at room temperature. Similar to 
the standard alkaline cornet assay defined by Singh et al (1988), treatment with 
alkali to unwind and denature the DNA followed by electrophoresis in neutral 
buffer permits the detection of single-strand breaks. These conditions, however, 
tend to give lower background levels of DNA damage, result in betler dose 
responses, and avoid saturating the assay so that estimation of damage is over a 
wider range (Koppen and Angelis, 1998; Angelis et al, 1999). 
DNA was stained with 50 !-IL of SYBR Green solution (Trevigen) diluted 
1:10 000 in Tris-EDTA buffer, pH 7.5, and immediately analyzed at 200x 
magnification using a DAGE-MTI CCD300-RC camera (DAGE-MTI Inc, Michigan 
City, Ind) atlached to an Olympus BX51 epifluorescence microscope. Fifty cells 
were randomly analyzed per slide for a total of 100 cells per animal, and 
fluorescent images were scored for cornet parameters. Tail length, percent tail 
DNA, and tail moment (tail length x fraction of tail DNA) were measured using the 
KOMET 5.0 image analysis system (Kinetic Imaging Ltd, Liverpool, United 
Kingdom). 
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Slalistical Analysis 
Significant differences due to drug treatment or time of drug exposure were 
determined using a 2-way analysis of variance followed by the Bonferroni post 
hoc test (P < .05). The percent abnormal sperm among populations of 
spermatozoa from saline- and cyclophosphamide-treated animais was compared 
by chisquare analysis. Statistical analyses were performed by the SigmaStat 2.03 
software package (SPSS Inc, Chicago, III). 
2.4 RESULTS 
ln the alkaline comet assay, an increase in DNA strand breaks leads to 
greater DNA migration out of the nucleus and into the tait of the comet. The 
majority of control spermatozoa had little if any cornet tail (Figure 2-1A). 
Differences in tait length and tail intensity were observed. among 
cyclophosphamide-exposed sperm populations (Figure 2-1 B through D). The 
extent of damage was dependent on dose as weil as on time and length of 
exposure to cyclophosphamide. 
Acufe 1-Day Exposure 
Exposure of male germ cells to a single high dose of cyclophosphamide resulted 
in time-specific increases in DNA damage (Figure 2-2). Small yet significant 
differences were observed only in the percentage of tail DNA values 14 days after 
drug administration (1.4-fold increase) and in taillength values after 14 days (1.2-
fold increase) and 21 days (1.7-fold increase). On the integration of these 2 
comet parameters to obtain the tail moment, significant differences between drug-
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exposed and time-matched controls were observed after 14 days (1.6-fold) and 
21 days (2.2-fold). Acute exposure to cyclophosphamide did not alter sperm DNA 
integrity after 28 days; this may indicate either a decrease in susceptibility to 
damage or the presence of repair in early spermiogenic germ cells. 
Subchronic 4-0ay Exposure 
Short-term repeat exposure to cyclophosphamide resulted in dose- and 
time-dependent increases in DNA damage (Figure 2-3). Sy day 14, no significant 
differences were seen between sperm exposed to low doses of 
cyclophosphamide and control sperm for any cornet parameters. Administration 
of a higher dose, however, resulted in significant differences in tait length (1.6-
fold) and tail moment (2.3-fold). Drug-exposed spermatozoa collected on day 21 
showed the highest levels of DNA strand breaks detected at any time point. 
Measurements of cornet tail moment after exposure to low or high 
cyclophosphamide doses were 3.3- and 9.4-fold higher than for the control, 
respectively (Figure 2-3C). Similar changes were observed for the percentage of 
tait DNA and tait length; however, the magnitudes were not as great (Iow dose: 
2.4- and 2.2-fold increases, respectively; high dose: 3.8-fold increase for both 
parameters). Spermatozoa collected on day 28 had relatively lower levels of DNA 
strand breaks than spermatozoa collected on day 21. 
Chronic Exposure 
Significant increases in the percentage of tait DNA, tait length, and tail 
moment were detected at ail time points after chronic exposure to low doses of 
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cyclophosphamide (Figure 2-4). There were significant yet very small differences 
in the percent tail DNA for cyclophosphamide-exposed sperm populations at the 3 
time points. In contrast, the mean tail length showed a significant increase in 
damage from day 14 (80.1 J,Jm) to day 21 (102.8 J,Jm) and then a slight decrease 
by day 28 (94.2 J,Jm). Tail moments showed a 1.9-fold increase in DNA damage 
after 14 days; damage was maximal by 21 days of chronic cyclophosphamide 
exposure (3.4-fold increase). In comparison to the mean tail moments observed 
after low-dose subchronic exposure (Figure 2-3C), the mean tail moment values 
for each time point were much higher after chronic drug exposure, indicating an 
accumulation of cyclophosphamide-induced damage during the entire course of 
. drug administration. This increase in damage appeared to reach a plateau by day 
21, as there was no difference between the fold increases in damage for days 21 
and 28 (3.4- and 3.5-fold increases, respectively). 
Distribution of Sperm from Low to High Damage Groups 
Frequency histograms of tail moment represent the distribution of sperm 
damage. Tail moments for drug-exposed spermatozoa had a heterogeneous 
distribution pattern, ranging from 0 to 100, rather than discrete populations of low 
and high DNA damage. Differences in the percentage of sperm with increasing 
amounts of damage were, however, still noticeable. An overwhelming majority 
(~94%) of tail moments for control animais ranged from 0 to 15; therefore, in 
comparison, the percentage of abnormal sperm with tail moments greater than 15 
in drug-treated populations was calculated (Figure 2-5). 
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Signiticant increases in the percentage of abnormal sperm were seen at ail 
time points among the cyclophosphamide-treated group in the high-doselacute 
study (Figure 2-5A). By day 14, 12% of sperm were damaged, while by day 21, 
10% of sperm had tail moments above 15. Note that although no significant 
difference was found between tail moment means of drug-exposed and control 
sperm at day 28 (Figure 2-2C), there was still a higher number (14%) of sperm 
from cyclophosphamide..:treated animais with abnormal DNA. For the subchronic 
cyclophosphamide study, the highest percentage of abnormal sperm was found 
within the population of cells collected after 21 days for both low and high 
cyclophosphamide doses (12% and 32%, respectively; Figure 2-5B). In the day 
28 high-dose cyclophosphamide-exposed sperm, signiticant differences were 
found, even though the tail moment mean was not significantly different from 
controls. At days 14 and 28, only sperm collected after high-dose 
cyclophosphamide administration had a significantly higher than control 
percentage of sperm with increased DNA damage. 
Chronic low-dose administration of cyclophosphamide resulted in a 
signiticant increase in the percentage of abnormal sperm compared to controls 
(Figure 2-5C). Only 13% of sperm presented with ab normal DNA (2.6-fold 
increase) by day 14. Cyclophosphamide-induced damage accumulated in 22% of 
the germ cells that were tirst exposed during mid-spermiogenesis and collected 
21 days later (4.1-fold increase). The percentage of abnormal sperm did not 
further increase by day 28. 
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2.5 DISCUSSION 
Using alkaline elution, previous studies (Qiu et al, 1995b) have shown that 
6 weeks of chronic cyclophosphamide treatment significantly increases both DNA 
single-strand breaks and cross-links in spermatozoa. Chronic exposure to 
cyclophosphamide, targeting spermatids and epididymal spermatozoa, resulted in 
increases in peri-implantation embryo loss and fetal growth retardation and 
malformations (Trasler et al, 1985, 1986, 1987). The goal of this study was to 
elucidate the extent of DNA damage in spermatozoa induced by 
cyclophosphamide at specific spermiogenic time points. The cornet assay is a 
sensitive measure· of DNA damage in individual sperm nuclei, thus making it 
possible to determine whether or not ail cells within a population demonstrate the 
same degree of damage. Only a few studies have used the cornet assay to 
assess genotoxic damage to male germ cells after in vivo exposure to a testicular 
genotoxicant (Anderson et al, 1996; Haines et al, 2001,2002). 
The germ cell phase most sensitive to the induction of mutations by 
cyclophosphamide was the early spermatid phase (Sotomayor and Cumming, 
1975). As measured by the cornet assay, the mid-spermiogenic germ cells were 
most susceptible to DNA damage after cyclophosphamide exposure. These data, 
and those of Haines et al (2002), on germ ceU phase-specific susceptibility to 
radiation damage suggest that the cornet assay is not predictive of subtle 
mutational changes. However, high amounts of DNA damage as detected by the 
cornet assay have been associated with the failure of embryo development after 
intracytoplasmic sperm injection (Morris et al, 2002) and with infertility in humans 
(Irvine et al, 2000). The DNA damage measured by the cornet assay may also 
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provide an accu rate reflection of adverse reproductive outcome after chronic low-
dose administration of cyclophosphamide to male rats (Trasler et al, 1985, 1986, 
1987). 
Cyclophosphamide exposure resulted in dose-dependent and time-specific 
increases in the levels of DNA damage; as dose and exposure time increased, so 
did the fraction of cells with DNA damage. Acute exposure to a high dose of 
cyclophosphamide did not create any major elevations in damage, and the 
damage that was noted was readily reversibJe. Step 9 and 15 spermatids 
collected as spermatozoa on days 21 and 14, respectively, incurred only low 
levels of damage. Acute cycJophosphamide exposure affected gene expression 
most dramatically in round spermatids; the expression of DNA repair genes was 
induced (Aguilar-Mahecha et al, 2001). These data suggest that round 
spermatids attempt to compensate for DNA damage induced by the drug. Neither 
acute nor subchronic cyclophosphamide exposure resulted in a significant 
increase in damage in germ cells exposed to the drug as round spermatids 
(acute: step 1 spermatids, subchronic: steps 1-5 spermatids). Postmeiotic 
spermatids do not undergo apoptosis (Cai et al, 1997; Sinha Hikim and Swerdloff, 
1999; Brinkworth and Nieschlag, 2000); however, early to mid-spermatids do 
have the ability to repair DNA lesions (Sega, 1976; Sotomayor et al, 1978) that 
may give ri se to DNA strand breaks. The ultimate effect of cyclophosphamide on 
germ cens will depend on both the extent of damage and their ability to undergo 
DNA repair. While there was no significant increase in ove ra Il damage at this 
stage, there was still a discrete population of ab normal sperm presenting 
increased levels of damage, and these cells may be capable of affecting progeny. 
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Repeat exposure to cyclophosphamide was required for higher levels of 
damage to occur. Subchronic treatment of male rats produced maximal damage 
in elongating spermatids exposed to the drug from stages 9 to 14. Chronic 
administration of cyclophosphamide resulted in the greatest accumulation of 
damage over time; the damage reached a plateau after 21 days of drug 
treatment, at a time point when germ cells exposed to cyclophosphamide are 
developing from elongating spermatids (steps 9-19) to mature spermatozoa. 
Cyclophosphamide may exert its maximal effect on elongating spermatids and 
spermatozoa, since these cells have lost the ability to repair DNA and undergo 
apoptosis. 
Differences in susceptibility to genetic damage between mid- (steps 9-14) 
and late (steps 15-19) spermatids may be due to chromatin structural changes 
during spermiogenesis. The structural organization of DNA in the sperm may 
determine the participation of the paternal genome in embryo development. 
During spermiogenesis, mammalian sperm DNA is reorganized into loop domains 
attached at specific sites to the nucJear matrix (Ward and Coffey, 1991; Ward, 
1993). The unique chromatin architecture that results may be required to facilitate 
scheduled transcription after fertilization. DNase-l-hypersensitivity regions have 
been localized to transcriptionally active or potentially active genes near nucJear 
matrix attachment sites (Gross and Garrard, 1988). The pattern of DNase-l-
hypersensitivity regions changes during spermiogenesis; step 12-13 elongating 
spermatids are the most sensitive to enzymatic action (McPherson and Longo, 
1992). This stage of spermiogenesis may represent a point at which the male 
genome is more accessible to insult. In comparison, alkylating agents 
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preferentially damage DNA regions that are in close proximity to matrix-bound 
replication and transcription sites (Muenchen and Pienta, 1999). The template 
function of spermatozoal DNA was markedly affected after 6 weeks of treatment 
with cyclophosphamide (Qiu et al, 1995b). During spermiogenesis, certain gene 
loci may be more susceptible to cyclophosphamide alkylation; we hypothesize 
that these genes play an important role in regulating early embryo development. 
Final packaging of the sperm DNA occurs as histone acetylation and 
ubiquitination increase in mid-spermiogenic spermatids to allow transition proteins 
to bind to the DNA. These transition proteins then facilitate the preferential 
binding of protamines in late spermatids to condense the chromatin (Poccia, 
1986; Wouters-Tyrou et al, 1998). Endogenous nicks in DNA, present normally in 
step 12-13 rat spermatids, are ligated before the completion of protamination 
(McPherson and Longo 1992, 1993a,b; Sakkas et al, 1995). These nicks may be 
present to facilitate protamination by providing relief of tortional stress 
(McPherson and Longo, 1992). Improper ligation of these breaks may result in 
altered chromatin structure and residual DNA strand breaks in spermatozoa 
(Sailer et al, 1995; Caron et al, 2001; Kierszenbaum, 2001). The presence of 
DNA damage in mature spermatozoa has been correlated with poor chromatin 
packaging (Gorczyca et al, 1993; Sailer, 1995; Manicardi et al, 1998), possibly 
due to underprotamination (Manicardi et al, 1995; Sakkas et al, 1996). 
Cyclophosphamide may affect the relationship between protamination and 
endogenous nick creation and ligation. Thus, cyclophosphamide maximally 
damages DNA at its most vulnerable state, during mid-spermiogenesis, when 
nucleoproteins are involved in the histone-protamine exchange. 
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Decreased iodoacetamide binding, indicating decreased reducible 
sulfhydryl content of sperm nuclei, was obser\ted in cyclophosphamide-exposed 
germ ceUs, suggesting that protamine is affected in these cells (Qiu et al, 1995a). 
Effects on reducible sulfhydryl content may be due to either incomplete protamine 
deposition or an increase in alkylation of protamine sulfhydryl groups. Protamines 
in the testis may be especially susceptible to alkylation; if so, the end result would 
be blockage of normal disulfide bond formation, thus preventing proper chromatin 
condensation. This could lead to stress in the chromatin structure and result in 
DNA strand breaks (Sega and Owens, 1983). Fertilization with damaged or poor-
quality sperm may le ad to aberrant pronuclear development (Lopes et al, 1998a). 
Indeed, male pronulear formation was early in rat oocytes sired by 
cyclophosphamide-treated males (Harrouk et al, 2000b). Sega and Owens (1983) 
have paralleled patterns of alkylation of protamine in late spermatids and early 
spermatozoa to the occurrence of dominant lethal mutations. 
ln summary, cyclophosphamide-induced DNA damage accumulates over 
time, with the most damaging effects occurring during mid-spermiogenesis. The 
step 9-14 spermatids appear to be most susceptible to DNA damage; this 
represents a key time point in sperm chromatin remodeling (histone acetylation 
and transition protein deposition). Fertilization can be achieved using damaged 
spermatozoa; however, proper embryo development depends on spermatozoal 
genetic integrity (Ahmadi and Ng, 1999). In previous studies, using the comet 
assay, we have shown that cyclophosphamide-exposed spermatozoa imparted 
significantly greater DNA damage to fertilized eggs at the single-cell stage than 
did control spermatozoa (Harrouk et al, 2000a). Given the results of the present 
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study, we speculate that cyclophosphamide disrup~s chromatin remodeling, 
hence affecting sperm chromatin structure and embryo development. 
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FIGURES and LEGENDS 
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Figure 2-1. Images of spermatozoal nuclei following the cornet assay. (A) Control 
sperm; (8-0) cyclophosphamide-exposed sperm. Ali images are at 200x 
magnification. Scale bar = 40lJm. 
102 

Figure 2-2. DNA damage assessed by the cornet assay in epididymal 
spermatozoa on days 14, 21 and 28 after acute 1-day cyclophosphamide 
exposure. Effects measured as (A) % tail DNA, (8) tai! length and (C) tail moment 
are shown for saline (open bars) and cyclophosphamide-exposed (crosshatched 
bars) sperm populations. The data shown represent means ± SEM (n= 3). 
*Significantly different from time-matched controls (P<0.05). 
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Figure 2-3. DNA damage assessed by the cornet assay in epididymal 
spermatozoa on days 14, 21 and 28 after sub-chronic 4-day cyclophosphamide 
exposure. Effects measured as (A) % tail DNA, (8) tai! length and (C) tail moment 
are shown tor saline (open bars), low-dose cyclophosphamide (crosshatched bars) 
and high-dose cyclophosphamide (black bars) sperm populations. Data shown 
represent means ± SEM (n= 3). * Significantly different trom time-matched 
controls; § significantly different trom time-matched low-dose cyclophosphamide 
group; 1f significantly different trom dose-matched day 21 cyclophosphamide group 
(P<0.05). 
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Figure 2-4. DNA damage assessed by the cornet assay in epididymal 
spermatozoa on days 14, 21 and 28 after chronic cyclophosphamïde exposure. 
Effects measured as (A) % taïl DNA, (8) taïl length and (C) taïl moment are shown 
for saline (open bars), and cyclophosphamide-exposed (crosshatched bars) sperm 
populations. Data shown represent means ± SEM (n= 4). * Significantly different 
from time-matched controls; 11 significantly different from dose-matched day 21 
cyclophosphamide group (P<0.05). 
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Figure 2-5. Percentage of epididymal spermatozoa with tail moments greater than 
15. CeUs were coUected on days 14, 21 and 28 after (A) acute 1-day, (8) sub-
chronic 4-day and (C) chronic cyclophosphamide exposure and then analysed for 
DNA damage measured as cornet tait moment. The percentage of abnormal 
sperm presenting increased DNA damage is shown for saline (open bars), low-
dose cyclophosphamide (crosshatched bars) and high-dose cyclophosphamide 
(black bars). TM indicates tait moment. * Significantly different from time-matched 
controls; § significantly different from time-matched low-dose cyclophosphamide 
group (P<0.05). 
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Connecting Text 
ln the previous study we found that cyclophosphamide induced DNA 
damage in a spermiogenic germ cell-phase specifie manner, thus highlighting the 
susceptibilities of the spermatids to genetic damage. This time of exposure 
targets the germ cell as it remodels its chromatin to condense the nucleus and 
form the mature spermatozoon, a process that requires the involvement of 
diverse proteins. This unique event could be altered by drug-induced damage. 
The second objective of this thesis assessed the effects of cyclophosphamide 
exposure on two aspects which establish spermatozoal chromatin structure, 
chromatin condensation and basic proteome expression. 
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CHAPTER 3 
Exposure of Male Rats to Cyclophosphamide Alters the 
Chromatin Structure and Basic Proteome in Spermatozoa 
Alexis M. Codrington, Barbara F. Hales and Bernard Robaire 
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3.1 ABSTRACT 
BACKGROUND: The formation of mature sperm involves the expression of 
numerous proteins during spermiogenesis and the replacement of histones with 
protamines to package the genome. Exposure to cyclophosphamide (CPA), an 
anticancer alkylating agent, during spermiogenesis may disrupt chromatin 
condensation with adverse consequences to the. offspring. METHODS: Adult 
male rats were given CPA in one of two schedules: 1) sub-chronic, 4 days - day 
1, 100mg/kg and days 2 - 4, 50mg/kg/day or 2) chronic - daily, 6.0mg/kg/day. 
Animais were euthanized on days 14, 21 or 28. RESUL TS: The effects of CPA 
on epididymal sperm chromatin structure were germ cel/-phase specific; mid-
spermiogenic spermatids were most sensitive. The SCSA ® 1 acridine orange 
DNA denaturation assay showed significant increases in susceptibility to 
denaturation (P<O.01). Chromatin packaging assessment revealed 1,4-
dithiothreitol-dependent chromomycin A3 DNA binding, and less condensed, 
protamine-deficient sperm; the total thiol (P<O.001) and protamine contents 
(P<O.01), measured using monobromobimane and the HUP1N protamine 1 
antibody, respectively, were reduced. The sperm basic proteome was also 
altered; proteins that were identified are involved in events during 
spermiogenesis and fertilization. CONCLUSIONS: Paternal exposure to CPA 
alters sperm chromatin structure, as weI/ as the composition of sperm head basic 
proteins. We speculate that these changes underlie effects on fertilization and 
embryo development. 
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3.2 INTRODUCTION 
Mature spermatozoa are organized and packaged in a specific manner to 
ensure transmission of genetic material to the offspring and successful 
pregnancy. The unique structure of sperm and stability of the DNA is due to a 
sequence of events that occur to shape, condense and protect the nucleus; the 
most important of these involves a loss of the bulky nucleosomal structure in 
elongating spermatids as transition proteins transiently replace histones. This 
exchange facilitates the preferential binding to DNA of highly basic, cysteine-rich 
protamines in late spermatids (Poccia, 1986; Wouters-Tyrou et al., 1998) 
Further stabilization is accomplished by the formation of intra- and intermolecular 
protamine disulfide bonds as cysteines progressively become oxidized during 
sperm epididymal transit (Shalgi et al., 1989). Perturbation of events at any point 
of spermiogenesis or sperm maturation may affect sperm function. 
Indeed, human male infertility has been associated with changes in sperm 
chromatin integrity and packaging (Evenson et al., 1999; Irvine et al., 2000; 
Spano et al., 2000), as weil as with changes in protamine content and affinity to 
DNA (Belokopytova et al., 1993; Torregrosa et al., 2006). Exposure to 
chemotherapeutic agents results in increased DNA damage in human 
spermatozoa (Chatterjee et al., 2000; Morris, 2002); such damage has been 
associated also with abnormal sperm chromatin packaging (Manicardi et al., 
1995; Manicardi et al., 1998). 
A commonly used anticancer drug, cyclophosphamide (CPA), is a 
bifunctional alkylating agent and well-known male mediated developmental 
toxicant with clear stage-specific effects on male germ cells (Anderson et al., 
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1995; Trasler et al., 1985). Despite the appearance of morphologically normal 
spermatozoa, evidence of hidden anomalies exists (Bianchi et al., 1996), and 
may be the case in spermatozoa chronicallY exposed to CPA. Exposure of male 
germ cells to CPA during spermiogenesis and epididymal transit leads to DNA 
single-strand breaks, crosslinks, and altered in vitro spermatozoal 
decondensation and template function (Qiu et al., 1995a; Qiu et al., 1995b) in 
cauda epididymal sperm, and to pre- and post-implantation embryo loss as weil 
as growth retarded progeny (Trasler et al., 1986). The most damaging effects to 
DNA occurred during mid-spermiogenesis, as the histone-protamine exchange 
begins (Codrington et al., 2004). Exposure to CPA at this time may alter the 
binding of protamines to DNA due to increased DNA damage, as weil as result in 
protamine alkylation, given that protamines are known to be especially 
susceptible to alkylation (Sega and Owens, 1983). If this is the case, the end 
result may be faulty or incomplete protamine deposition and blockage of normal 
disulfide bond formation, thus preventing proper chromatin condensation and 
limiting fertilizing ability. 
The formation of mature sperm involves the controlled, sequential 
expression of a large number of proteins during spermiogenesis. Paternal CPA 
exposure alters gene expression in male germ cells (Aguilar-Mahecha et al., 
2001; Aguilar-Mahecha et al., 2002). These changes in gene expression may be 
translated into an altered protein expression profile, which could be important for 
spermiogenic events and fertilization; the characterization of sperm proteins 
should identify such changes. 
116 
Sperm count, viability, membrane fluidity, capacitation status, acrosomal 
integrity, and mitochondrial function, as weil as DNA integrity, and chromatin 
structure and packaging can be measured rapidly in a large number of 
spermatozoa by using flow cytometry (Gillan et al., 2005). The value of flow 
cytometry to study mammalian sperm has been recognized in the areas of 
reproductive toxicology (to monitor effects from environmental, occupational and 
therapeutic exposures), and clinical andrology (to assess individual fertility 
potential) (Spano and Evenson, 1993). A multiplex approach, combining flow 
cytometry assays with proteomic and genomic methods, should improve our 
ability to predict fertility status and help identify susceptible subpopulations at risk 
for infertility. This study uses such an approach to elucidate the effects of CPA 
on chromatin structure and on the expression of sperm head basic proteins in the 
rat. 
3.3 MATERIALS AND METHODS 
Animal Treatments 
Adult male Sprague-Dawley rats (400-450 g) were obtained from Charles 
River Canada (St. Constant, OC, Canada), maintained on a 14L:10D light cycle 
and provided with food and water ad libitum. Rats were gavaged with saline or 
CPA (CAS 6055-19-2, Sigma-Aldrich Ltd., Oakville, ON, Canada) in one of two 
schedules: 1) high dose/sub-chronic, 4 days - day 1, 100 mg/kg and days 2 - 4, 
50 mg/kg/day; 2) low dose/chronic - daily, 6 mg/kg/day. To capture cauda 
epididymal spermatozoa first exposed to CPA during late, mid and early 
spermiogenesis, animais were euthanized by decapitation on days 14, 21 or 28 
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after initiation of treatment (Clermont, 1972). Animal handling and care were 
done in accordance with the guidelines established by the Canadian Council on 
Animal Care. 
Sperm Collection 
Epididymides were first removed, trimmed free of fat and washed in 6ml of 
pre-chilled 1X phosphate buffered saline (PBS), pH 7.4 (Roche Diagnostics, 
Laval, QC, Canada). The caput and cauda regions were removed and 
transferred to separate sterile Petri dishes containing 8ml of fresh PBS on ice. 
Each region was thoroughly minced with sterile scalpels. The tissue was left for 
5 min on ice to a"ow the spermatozoa to disperse and was then strained through 
a BD Falcon 70J..lm nylon ce" strainer 0JWR International Co., Mississauga, ON, 
Canada), washed with 2ml of fresh PBS, and the total ce" suspension was 
centrifuged at 1000 x 9 for 10 min at 4°C. The pellet was washed twice in 10ml of 
0.45% NaCI, once in PBS, then resuspended in 4ml of PBS containing 40J..lI of 
protease inhibitor cocktail (Sigma-Aldrich, Ltd.). Aliquots were stored at -80°C. 
Cauda epididymal sperm used for protein extraction were further 
processed according to the method of Yu and co"eagues (Yu et al., 2000), with a 
few modifications. Fo"owing the final wash in PBS, sperm were resuspended in 
4ml of water containing 40J..lI of protease inhibitor cocktail. After sonication on ice, 
sperm heads were isolated using discontinuous sucrose gradients (Calvin, 1976) 
made with a 0.2X concentration of MP buffer (5mM MgCI2, 5mM sodium 
phosphate, pH 6.5) containing 0.25% Triton X-100. Twelve milliliters of sonicated 
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sperm in 1.80M sucrose were layered over 13ml each of cold 2.05M and 2.20M 
sucrose and centrifuged at 91,400 x gin a Beckman SW 28 rotor for 70 min at 
4°C. The pellet was washed in MP buffer and then frozen at -80°C. 
SCSA ® / Acridine Orange DNA Denaturation Assay 
Altered chromatin structure measured by the susceptibility of sperm DNA 
to acid-induced denaturation was assessed with the metachromatic dye, acridine 
orange (AO) (Sigma':'Aldrich Ltd.), based on a method previously described 
(Evenson and Jost, 2000). The dye f1uoresces green when bound to double 
stranded DNA and red when bound to single stranded or denatured DNA. 
Samples of spermatozoa from the cauda epididymidis were placed in a 37°C 
water bath until thawed, immediately placed on ice and then sonicated to 
separate tails from heads. Two hundred microliters of the 1-2 x 106 sperm/ml 
samples were mixed with 400~1 of a solution containing 0.08N HCI, 0.1 % Triton 
X-100, and 150mM NaCI, pH 1.4 to denature sperm DNA. After 30 seconds, 
1.2ml of AO staining solution (O.2M Na2HP04, 0.1 M citric acid buffer, 1 mM EDTA, 
150mM NaCI, pH 6.0 and 6.0~g/ml AO) was added. 
Exactly 2.5 min after the addition of the staining solution, the samples 
were vortexed and analyzed using a BD FACScan Analyzer System (BD 
Bioscience, San Jose, CA) fitted with a 488nm argon-ion laser. Green 
fluorescence was detected with 502LP and 530/30BP filters. Red fluorescence 
was detected with 670LP and 660/20BP filters. A total of 10,000 sperm were 
analyzed per sam pie (n=6-8) and each sample was measured twice. 
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Raw data were processed using Win List Software (Verity Software, 
Topsham, ME, USA). The extent of ONA denaturation was determined by 
calculating the ONA fragmentation index (OFI), which represents the shift from 
green to red fluorescence and is the ratio of denatured ONA (red intensity) to total 
ONA (red + green intensity). For each sample, the mean OFI, indicating shifts 
within a population of cells and percent abnormal sperm with denatured ONA, 
defined as %OFI, were calculated. 
Chromomycin A3 Staining 
The state of sperm chromatin packaging was assessed based on the 
accessibility of the f1uorochrome, chromomycin A3 (CMA3) (Sigma-Aldrich Ltd.) 
(Bianchi et al., 1993). This assay was done with the following modifications. 
Aliquots of spermatozoa from the caput and cauda epididymidis were first thawed 
and sonicated on ice. Following one wash in cold PBS, spermatozoa were 
incubated in 0, 0.1, 0.2, 0.5, 1,2, 5, 10 or 20mM of 1,4-dithiothreitol (OTT) in PBS 
for 10 min at 37°C, and then washed in PBS. Five hundred microliters of CMA3 
solution (0.25mg/ml CMA3 in Mcllvaine buffer, 0.1 M citric acid, 0.2M Na2HP04, 
pH 7.0, containing 10mM MgCb) was added to each sample and incubated for 20 
min at 25°C in the dark. The samples were finally resuspended in 1 ml Mcllvaine 
buffer and stored at 4°C in the dark until analysis the next day. 
Spermatozoal heads were analyzed using a MoFlo High Performance Cell 
Sorter (Cytomation Inc., Fort Collins, CO, USA) equipped with an argon laser 
(457nm line excitation) and a 460/10 filter. The fluorescence emitted was 
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detected with a 580/30 bandpass tilter and quantified using Summit v3.1 software 
(Cytomation Inc.). A total of 10,000 sperm were analyzed for each sam pie (n=4). 
Monobromobimane Thiot Labeling 
Thiol labeling was done according to Shalgi et al. (1989), with minor 
modifications. Aliquots of spermatozoa from the caput and cauda epididymidis (4 
x 106 ceUs/ml) were sonicated on ice and incubated with or without 1 mM OTT in 
PBS at 37°C for 10 min. Samples were washed twice and resuspended in PBS. 
A 50mM monobromobimane (mBBr) (Calbiochem, San Diego, CA, USA) stock 
solution was prepared in acetonitrile and added to the sperm suspensions to a 
final concentration of 0.5mM in the dark for 10 min. Sperm were washed twice 
with PBS and stored in the dark at 4°C until analysis the next day. 
Flow cytometric analysis was done using a MoFlo High Performance CeU 
Sorter (Cytomation Inc.) equipped with an argon laser (UV excitation). MBBr 
fluorescence emission was detected with 450/65 and dichroic 510LP filters. 
Quantification was done using Summit v3.1 software (Cytomation Inc.). A total of 
10,000 sperm were analyzed for each sample (n=4). 
Protamine tmmunostaining 
Aliquots of cauda epididymal spermatozoa (3 x 107 ceUs/ml) were 
resuspended in 1ml of solution containing 1% SOS, 50mM Tris-HCI pH 7.5, 1mM 
EDTA, and protease inhibitor cocktail (1:100 dilution) for 10 min at room 
temperature to remove peri-nuclear material. The samples were then cooled on 
ice for 5 min, sonicated for 5 sec and washed three times with 50mM Tris-HCI pH 
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7.5. Before the last wash, samples were divided into three groups and then 
resuspended in 1ml decondensation buffer (25mM Tris-HCI, pH 7.5 and 10Jjl 
protease inhibitor cocktail) containing 0, 1 or 20mM DIT for 1 hr at room 
temperature. Ten microliter droplets were placed on slides (two sam pie areas 
per si ide) and left on ice for 20 min to allow cells to setlle and adhere to the 
slides. Slides were then washed 3 x 2 min in PBS, fixedin 2% paraformaldehyde 
for 20 min at room temperature and washed again. 
Siides were first blocked with 2% normal goat serum (Vector Laboratories 
Inc., Burlington, ON, Canada) and 1 % bovine serum album in (BSA, Sigma-
Aldrich, Ltd.) in PBS (200Jjl per sample area) for 30 min at room temperature. 
Subsequently, cells were covered with 200Jjl of primary antibody solution 
containing 1% BSA and HUP1N monoclonal human protamine 1 antibody (1:100 
dilution, kindly provided by Dr. Rod Balhom, Lawrence Livermore National 
Laboratory) in PBS, ovemight at 4°C, washed with PBS (3 x 2 min), covered for 
1.5 hrs in the dark with 200Jjl of secondary antibody solution containing 
fluorescein-conjugated mouse Ig antibody (1:150 dilution, Amersham 
Biosciences, Baie D'Urfe, QC, Canada) in PBS, and finally washed three times in 
PBS. Siides were covered with Vectashield mounting medium containing DAPI 
(Vector Laboratories Inc.) and kept at 4°C in the dark. 
Pictures were taken using a DAGE-MTI CCD300-RC camera (DAGE-MTI 
Inc., Michigan City, IN, USA) atlached to an Olympus BX51 epifluorescence 
microscope. Fluorescence intensity and sperm head area were measured using 
the MCID Elite 6.0 image analysis system (Imaging Research Inc., St. 
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Catharines, ON, Canada). Fifty cells were randomly chosen for analysis from 
each sample area for a total of one hundred cells per group (n=3). 
Protein Extraction 
Cauda epididymal sperm head proteins were extracted according to the 
method of Balhorn et al (1977) with the following modifications. Every step was 
done at 4°C. Pellets were dissolved in 5M guanidine-HCI, 10mM Tris pH 8, 
EOTA pH 8, 100mM OTT and protease inhibitor cocktail (1 :100 dilution) for 30 
min. After sonication for 1 min, urea, 2-mercaptoethanol and NaCI were added to 
give a final concentration of 0.5M guanidine-HCI, 3M urea, 0.5M 2-
mercaptoethanol and 2M NaCI for 1 hr. HCI was added to a concentration of 
0.5M for 1 hr to precipitate the DNA, and the DNA pelleted by centrifugation at 
18,300 x 9 for 10 min. The supernatant was dialyzed against 0.01N HCI and 
10mM OTT with two changes of solution using 3500 Da dialysis cassettes 
(Pierce, Rockford, IL, USA). Proteins were precipitated with 25% trichloroacetic 
acid for 1 hr, the precipitate pelleted at 21,000 x 9 for 10 min, washed once with 
cold acid-acetone (1drop 5N HCI in 10ml acetone), once with cold acetone, and 
then air-dried. Samples were stored at 4°C. 
20 Basic Gel Electrophoresis 
Protein separation and analyses were conducted by the McGiII University 
and Genome Ouebec Innovation Centre (Montreal, OC, Canada) using material 
from Invitrogen Inc. (Burlington, ON, Canada), except where noted, and the 
Invitrogen ZOOM IPGRunner System protocol. Fifty micrograms of protein were 
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resuspended in 155J.11 of rehydration buffer (9.8M urea, 10mM 1,4-dithioerythritol, 
4% CHAPS, 20mM Tris) supplemented with 1% ZOOM® Focusing Buffer pH 7-
12. ZOOM® Dry Strips, pH 9-12 were rehydrated for 16-18 hrs and isoelectric 
focusing (IEF) done with a voltage gradient (200V- 2000V) applied as 
recommended by the manufacturer. After IEF was complete, strips were 
equilibrated with 1X NuPAGE® LOS Sample Buffer containing 2% OTT and then 
alkylated with iodoacetamide. Both steps were done at room temperature for 15 
min. Electrophoresis in the second dimension was done on 4-20% Tris-Glycine 
precast gels in XCell SureLock™ Mini-Cells filled with Tris-Glycine SOS Running 
Buffer. Broad range protein molecular weight markers (0.9 J.lg/gel, Amersham 
Biosciences) were used and 125V were applied for 1.5 hrs. Gels (n=5) were 
silver stained, scanned and analyzed with Phoretix 2004 Image Analysis software 
(Amersham Biosciences). Following background subtraction and normalization, 
intensities of the spots were calculated. One gel was then chosen as a reference 
and the other gels compared to the reference gel to create an average control 
and CPA gel, which were then compared. Spots were considered if present in at 
least three out of five gels and protein expression was considered changed only if 
the difference was at least 1.5-fold; this is equivalent to an increase of 50% or 
decrease of 33%. 
Mass Spectrometry 
Selected spots were excised from the gel and subjected to trypsin 
digestion on a robotic MassPREP Station (Waters-Micromass, Milford, MA, USA), 
as per the manufacturer's instructions. Gel pieces were tirst washed twice with 
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water for 20 min, destained twice in a 120fJI solution of 30mM potassium 
ferricyanide and 100mM sodium thiosulfate mixed 1: 1 for 15 min and then 
dehydrated with 75fJI of 100% acetonitrile. Samples were reduced, in the dark, 
with 50fJI of 10mM OTT for 30 min followed by alkylation with 50fJI of 55mM 
iodoacetamide for 20 min and 100fJI of 100% acetonitrile for 5 min. After washing 
and dehydration in 100mM ammonium bicarbonate and 100% acetonitrile, 
respectively, gel pieces were covered and digested for 4.5 hours with 6 ng/fJl of 
trypsin gold (Promega, Madison, WI, USA) in 100mM ammonium bicarbonate. 
Peptides were extracted with 30fJI formic acid (FA) solution (1 % FA in 2% 
acetonitrile) for 30 min, twice with 12fJI FA solution and then 12fJI 100% 
acetonitrile for 30 min. 
Nanoflow chromatography of digested peptides was performed on an 
Agilent 1100 series nanopump (Agilent Technologies Inc., Mississauga, ON, 
Canada) at a flow-rate of 200nl/min. Sam pie injection and desalting were 
performed with an Isocratic Agilent 1100 series pump at 15 fJl/min for 5 min. A 
trapping column (Agilent) packed with Zorbax 300SB-C18 (5 x 0.3 mm) was used 
for sample desalting. Peptide separation was done with a Biobasic C18 (10 x 
0.075 mm) picofrit column (New Objective, Woburn, MA, USA). Peptides were 
eluted using a 20 min gradient with solvent A (0.1 % FA) and solvent B (95% 
acetonitrile:0.1%FA) from 90%Al10%B to 100%B. 
Matrix assisted laser desorption/ionization mass spectrometry (MALOI-
MS) was done with a MALOI Q-Time of Flight (ToF) Ultima instrument (Waters-
Micromass). Samples were spotted along with a saturated solution of alpha-
hydroxycinnamic acid in 50% acetonitrile. Peaklists for peptide mapping 
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searches were generated with Proteinlynx v.1.5 (Waters-Micromass). Searches 
were performed with Mascot 1.9 using carbamidomethyl cysteine as a fixed 
modification, methionine oxidation as a variable modification and a precursor 
mass tolerance of 0.3 Da. 
Statistical Analysis 
Significant differences were determined using two- and three-way analysis 
of variance foUowed by the Holm-Sidak post-hoc test (p < 0.05). The percent 
abnormal sperm with denatured DNA among populations of spermatozoa from 
control and CPA-treated animais was compared by Chi-square analysis. 
Statistical analyses were done using the SigmaStat 3.0 software package (SPSS 
Inc., Chicago, IL). 
3.4 RESULTS 
Sperm Chromatin Structure 
Altered sperm chromatin structure has been attributed to changes in 
protamine content and the thiol-disulfide status of proteins (Aoki et al., 2005; 
Kosower et al., 19Q2; Love and Kenney, 1999; Pina-Guzman et al., 2005; Sailer 
et al., 1995; Zini et al., 2001). The SCSA® tAO DNA denaturation assay was 
used for a general assessment of the effects of CPA exposure on sperm 
chromatin structure. DNA in sperm with abnormal chromatin structure showed 
increased red fluorescence yielding a broader distribution of DFI values with an 
increase in mean DFI and more ceUs with denatured DNA (%DFI). Figure 3-1A 
shows that chronic CPA treatment for 28 days, exposing spermatids throughout 
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spermiogenesis and epididymal maturation, resulted in a 1.2-fold increase in the 
mean OFf of treated spermatozoa, compared to controls. Sub-chronic exposure 
resulted in significant increases in mean OFI values in spermatozoa exposed to 
the drug only at the end of spermiogenesis (14 days), when they were elongated 
spermatids, and during mid-spermiogenesis, as efongating spermatids (21 days). 
Cells collected after 28 days, and therefore first exposed as round spermatids, 
exhibited no increase in mean OFI. 
The percentage of sperm with denatured ONA was dramatically higher in 
drug-exposed samples (Figure 3-18). Chronic exposure resulted in a 6.9-fold 
increase in %OFI. Sub-chronic treatment revealed significant increases in the 
%OFI in spermatozoa collected after 14 days (3.8-fofd) and 21 days (6.9-fold). In 
contrast, there was no significant difference in %OFI in cells targeted as round 
spermatids. Mid-spermiogenic elongating spermatids were most sensitive to the 
effects of CPA; exposure at this time appears to account for most of the 
abnormalities seen following chronic exposure. 
Protamination and Condensation Status of Sperm 
Chronic CPA exposure showed no CMA3 staining above background 
levels in either control or drug-exposed cauda epididymal spermatozoa, 
suggesting no change in protamine content (Figure 3-2A, OmM OTT); however, 
sperm condensation by protamine disulfide bond formation, in addition to the 
level of protamination, could be a limiting factor controlling fluorochrome 
accessibility. To determine whether thiol bonds do play a role in CMA3 binding, 
caput spermatozoa were examined. Indeed, less condensed immature caput 
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spermatozoa were CMA3 positive. Not only was fluorescence intensity 7 -fold 
higher in control caput sperm compared to control cauda sperm, but fluorescence 
intensity of CPA-exposed caput sperm was 1.6-fold higher then control cap ut 
sperm and 9-fold higher then CPA cauda sperm. 
The relationship between CMA3 ONA binding and chromatin condensation 
was further assessed by in vitro decondensation induced by the disulfide 
reducing agent, on (Figure 3-2A, inset). With increasing amounts of on, a 
concentration-dependent increase in staining was observed, suggesting that the 
thiol status or decondensation status of sperm does indeed affect CMA3 
accessibility and binding. In caput spermatozoa, with just 0.1 mM on, CMA3 
binding increased to levels significantly higher then in cells not treated with the 
reducing agent (control: 4-fold, chronic CPA: 3.8-fold). More importantly, the 
CPA-exposed cell population exhibited unique susceptibility at this concentration 
of on as fluorescence intensity was 1.6-fold higher than in controls. Maximum 
intensity in both groups was observed with 1 mM on (Figure 3-2A). 
ln cauda spermatozoa, higher concentrations of OTT were required in 
order to observe significant differences in CMA3 fluorescence intensity. One 
millimolar of on was needed to achieve a 9.2-fold increase in control cauda 
spermatozoa and 17.5-fold increase in CPA-exposed cauda spermatozoa, 
compared to those that were not treated with on. Notably, the only difference in 
CMA3 binding in cauda sperm due to drug treatment was seen using 1 mM on 
(1.9-fold increase, Figure 3-2A). Therefore, chromatin packaging, whether due 
to protamine deficiency or not, was affected by CPA exposure; however, such an 
affect was only evident after decondensing the cells with 1 mM on. lt appears 
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that a certain thiol-disulfide status threshold had to be passed before CMA3 
binding was achieved. These results suggest that CPA-exposed spermatozoa 
were less condensed and/or were protamine deficient compared to control 
sperm. Cauda spermatozoa collected following sub-chronic exposure to CPA did 
not exhibit any changes in CMA3 ONA binding at any time point in the absence of 
on (Figure 3-28). However, in the presence of 1 mM on, significant 
differences (> 2-fold) due to CPA treatment were observed at ail time points, with 
no cell type being more sensitive than the other (Figure 3-28). 
Thiol-Disulfide Status 
Results·obtained using CMA31ead us to assess the thiol-disulfide status of 
spermatozoa by incubating cells with and without on, and then labeling them 
with m8Br. In Figure 3-3A, as expected the proportion of reactive thiols (SH 1 
(SH+SS», estimated from the mean fluorescence of sperm incubated without 
on (free thiols, SH) and the fluorescence of on pre-treated cells (total thiols, 
SH+SS), decreases as sperm mature from the caput to cauda epididymal 
regions. The effects of CPA were assessed in cauda sperm as weil as caput 
sperm, since the thiol status changes during epididymal transit as protamine 
disulfide bonds form. Using both cell types therefore also highlights any 
epididymal effects of CPA. Following chronic exposure to CPA, the fluorescence 
intensities of caput and cauda sperm not incubated with OTT were similar to 
controls. In contrast, total thiol levels significantly decreased by 5.7% in caput 
and 10% in cauda spermatozoa pre-treated with OTT compared to controls, thus 
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indicating that not only were thiol groups affected during epididymal transit, but 
also that the effect occurred before cells reached the caput epididymal region. 
Sub-chronic CPA exposure revealed a decrease in total thiols (7.4%) only 
in cauda sperm collected after 21 days, representing an effect on mid-
spermiogenic spermatids (Figure 3-3B). No other ceU type exposed to CPA, and 
incubated with or without on showed an effect different from that of controls. 
Protamine Content 
Protamines are the main basic protein present in spermatozoal heads. To 
follow-up on results obtained using CMA3 and mBBr, which point to the 
possibility of protamine deficiency in mature spermatozoa following CPA 
exposure, the level of protamination was assessed in cauda epididymal sperm. 
By the time spermatozoa enter the epididymis protamination is complete, 
therefore only cauda sperm were required for this assessment. Protamine 1 (P1) 
detection in cauda spermatozoa was dependent on the extent of decondensation 
induced by OTT; differences due to chronic drug treatment were only evident if 
cells were pre-treated with on (Figure 3-4A). Minimal fluorescence was seen in 
both control and CPA-exposed sperm in the absence of OTT (Figure 3-4B). With 
increasing concentrations of OTT, the amount of protamines detected 
significantly increased in control sperm. The fluorescence intensity of CPA-
exposed sperm was significantly different from control if on was used; 
compared to controls, less protamine was detected in CPA-exposed sperm. 
Differences in fluorescence between control and CPA-exposed sperm were not 
due to disproportionate decondensation because although sperm head areas 
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increased with increasing concentrations of DIT, they were not affected by CPA 
treatment (Figure 3-4C). Thus, sperm head fluorescence intensity results show 
that protamine content was indeed lower following chronic CPA exposure (Figure 
3-40). 
Sperm Head Basic Profein Expression 
Sperm head proteins were analyzed by 20 basic gel electrophoresis. Five 
gels each were run for control and chronic CPA-treated sperm protein samples. 
The ove ra Il pattern of proteins was reproducible between experiments; protein 
profiles differed with treatment (Figure 3-5). The avèrage control gel (Figure 3-
5A) consisted of 68 protein spots that appeared in at least three out of five gels 
analyzed, corresponding to 73-98% of the total number of spots detected on 
individual gels. In comparison, 59 protein spots were found on the average CPA 
gel (Figure 3-5B), corresponding to 70-99% of ail spots appearing on individual 
gels. Eleven protein spots were uniquely expressed in control samples and two 
in CPA samples. Fifty-seven protein spots were expressed in both groups; 
analysis of protein expression changes > 1.5-fold revealed nine spots that 
increased and six that decreased following CPA exposure. 
Twenty-two spots were chosen for identification; however, we were only 
successful in confidently identifying 12; these spots are labeled in Figure 3-5 and 
summarized in Table 3-1. Three of the identified proteins (histone 4, HIST2H4; 
fatty acid binding protein 9, FABP9; and zona pellucida binding protein, ZPBP) 
were represented by at least two distinct spots on the gels, suggesting that these 
proteins are modified or exist in different isoforms. ZPBP was found as the 
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precursor (46.3 kOa) and mature protein (39.7kOa). Interestingly, the expression 
of the precursor increased by 68%, while that of the mature protein was not 
changed (:S 1.5-fold). 
Of note, protein fragments were identified from significant MALOI Q-ToF 
MS analysis results for peptides that only partially covered a protein sequence. 
Protein fragments may be proteolytic cleavage products, despite the use of 
protease inhibitors during sample preparation. Analyzed spots for two proteins 
(heterogeneous nuclear ribonucleoprotein A 1, HNRPA 1; and chromodomain 
helicase DNA binding protein 4, CH04) contained only a fragment of the 
identified protein; the masses of the proteins calculated from the 20 gel (11.8 and 
21.0 kOa, respectively) were below the expected masses of these proteins, 
calculated from their amino acid compositions (38.9 and 205.5 kOa, respectively. 
Peptides for HNRPA1 covered theamino acid sequence containing the RNA 
recognition motif 1 (RRM1), RRM2 and a phosphothreonine phosphorylation site. 
Those for CH04 contained the helicase superfamily C-terminal (HELICe) domain; 
the two chromatin organization modifier (CHROMO) domains, which play a role in 
the functional organization of the nucleus, were not present (data not shown). 
We do not know if the expression of the HNRPA1 and CH04 protein fragments 
(64% increase with CPA and no change, respectively) reflect the expression of 
the full-Iength proteins. 
The majority of proteins identified, with the exception of HNRPA 1, protein 
kinase R interacting protein 1 (PRKRIP1) and CH04, are known components of 
spermatozoal heads expressed in the nucleus, perinuclear theca (PT) 
subacrosomal layer and sheath, or on the surface of the sperm. Information 
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concerning the putative functions of these proteins was found in the NCBI non-
redundant and SWISS-PROT protein sequence databases or in the literature. 
ln general, these proteins are involved in transcription and translation regulation 
(HNRPA1, PRKRIP1 and CHD4), chromatin organization (CHD4, HIST2H4 and 
histone H2B (HIST1 H2BL), sperm structure and stability (FABP9), and 
fertilization (HIST2H4, HIST1 H2BL, ZPBP and beta-defensin 20). 
3.5 DISCUSSION 
Several alkylating agents, including ethylnitrosourea, methyl 
methanesulfonate, thiotepa and triethylenemelamine, have been reported to 
result in sperm chromatin structural changes, as measured by flow cytometry 
(Evenson et al., 1985; Evenson et aL, 1986; Evenson et aL, 1989; Evenson et aL, 
1993). In the present study, the SCSA® tAO DNA denaturation assay revealed 
significant epididymal sperm nuclear structural effects of CPA exposure; maximal 
changes occurred in mid-spermiogenic elongating spermatids. These findings 
are in accordance with our results using the cornet assay, which showed 
increased DNA damage after chronic exposure to CPA and a similar maximal 
sensitivity to the drug in elongating spermatids (Codrington et aL, 2004). 
Protamine content and thiol-disulfide status are sources of chromatin stability 
examined in this study and reduced chromatin stability can affect genetic 
integrity. CPA effects on chromatin condensation may lead to stress in the 
chromatin structure and result in DNA strand breaks. 
The fluorochrome CMA3 has been used as an indirect tool to detect 
abnormal sperm chromatin packaging, as increased CMA3 staining is indicative 
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of decondensed, protamine-depleted spermatozoa (Bianchi et al., 1993; Bianchi 
et al., 1996; Manicardi et al., 1995). It is thought that either CMA3 accesses DNA 
in the minor groove of the DNA helix (Behr et aL, 1969; Berman et al., 1985), 
making it a protamine competitor, or protamines bind within the major groove 
(Fita et al., 1983; Hud et aL, 1994; Prieto et aL, 1997) thereby possibly 
obstructing CMA3 access to the minor groove (Bizzaro et al., 1998). Classical 
CMA3 analysis, as documented in the literature and first developed using human 
and murine samples (Bianchi et al., 1993), failed to reveal an effect following drug 
exposure in rats. Mouse caput, corpus and cauda epididymal spermatozoa do 
not positively stain with CMA3 (Sakkas et al., 1995); however, in rats the thiol-
disulfide status of epididymal spermatozoal nuclei influences the binding capacity 
of CMA3. This and other studies (Shalgi et al., 1989) show that the proportion of 
reactive thiols decreases from -85% in caput spermatozoa to ..... 22% in cauda 
spermatozoa. 
Interestingly, CPA affected male germ cells exposed as round spermatids, 
altering both sperm chromatin packaging, as assessed with the CMA3 binding 
assay, and genetic integrity, as assessed with the cornet assay (Codrington et al., 
2004). While the reasons for this are unclear, it is possible that CPA-induced 
DNA damage in early-spermiogenic spermatids affects mRNA transcripts 
synthesized at this time that are required for spermatid differentiation, such as 
protamine 1 (P1). Decreased template function has been observed in sperm 
chronicallyexposed to this alkylating agent (Qiu et al., 1995a); this may result in 
transcription termination and truncated RNA molecules (Gray et al., 1991; Pieper 
et al., 1989; Pieper and Erickson, 1990). Indeed, studies on infertile men report 
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decreased P1 transcript levels, thereby affecting the P1 :P2 ratio and sperm 
chromatin structure (Aoki et al., 2005). P1, the only protamine expressed in rats, 
appears to be the most critical factor, in comparison to P2, for male fertili~y (Cho 
et al., 2001; Steger et al., 2003). Metabolites of CPA (phosphoramide mustard 
and acrolein) can alkylate nucleophilic sites of ONA, RNA and protein (Murthy et 
al., 1973; Sanderson and Shield, 1996). In addition to consequences of DNA 
dam~ge on mRNA transcription, CPA could also bind directly with transcripts and 
affect protein synthesis. 
Protamines are synthesized during mid- and late-spermiogenesis and bind 
to late elongated spermatid ONA (Kistler et al., 1996). CMA3 staining was at its 
highest in spermatozoa exposed to CPA as elongating mid-spermiogenic 
spermatids; this is best explained by decreased P1 expression, which in turn 
could account for the noted reduction in thiol content. These results substantiate 
previous findings from our laboratory that report decreased 14C-iodoacetamide 
binding in spermatozoal nuclei chronicaUy exposed to CPA; however, an effect 
was also seen in ceUs not pre-treated with OTT (Qiu et al., 1995b). 
Oiscrepancies may be accounted for by differences in the level of sensitivity of 
the methods used. In addition to decreased P1 content, an effect on available 
reactive thiols could be due also to increased alkylation of protamine thiol groups; 
protamines in the testis are especially susceptible to alkylation, thus blocking 
normal disulfide bond formation (Sega and Owens, 1983), preventing proper 
chromatin condensation, and altering sperm structure. Indeed, the thiol-disulfide 
status of protamines determines the AO fluorescence of spermatozoal nuclei, 
such that increased susceptibility to acid-induced ONA denaturation occurs if 
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ONA-associated protamines are poor in disulfides (Kosower et aL, 1992; Zini et 
aL, 2001). Previously, we reported earlier male pronuclear formation in rat 
oocytes fertilized by CPA-treated males, as weil as altered sperm chromatin 
decondensation, both in vitro and in denuded hamster oocytes (Harrouk et aL, 
2000; Qiu et al., 1995b). 
It would be of interest to examine modifications to protamines following 
CPA exposures that affect sperm chromatin structure, namely alkylation and 
phosphorylation. Protamine phosphorylation/dephosphorylation maybe required 
for proper chromatin condensation; shortly after their synthesis, protamines are 
phosphorylated, thereby facilitating their correct binding to ONA. Once the ONA-
protamine complex is formed, protamines are dephosphorylated and sperm then 
enter the epididymis where final chromatin condensation occurs (Oliva and 
Oixon, 1991; Pirhonen et aL, 1994). Standard 20 systems provide more 
information about a protein sample, but they do not resolve ail proteins present in 
a sample, especially basic proteins with isoelectric points above 9. The 20 basic 
protein system used in this study did not resolve and identify modified protamines 
because they are extremely basic and rich in disulfide bridges; however, histones 
were present on the gels. It is tempting to speculate that these may be residual 
nuclear histones, although somatic histones are known also to be present in the 
subacrosomal sheath of the perinuclear theca (PT) (Tovich and Oko, 2003). The 
PT, a specialized cytoskeletal structure under the acrosome and surrounding 
sperm nuclei, has been implicated in acrosome-nuclear docking· and nuclear 
shaping during spermiogenesis (Au 1 and Oko, 2002; Oko, 1995), as weil as in 
egg activation, and pronuclear formation (Kimura et al., 1998; Manandhar and 
136 
Toshimori, 2003; Sutovsky et aL, 1997; Sutovsky et aL, 2003); the potential exists 
for PT -derived histones to contribute to male pronuctear development. 
The histone-protamine exchange occurs along with other functionally 
important spermiogenic morphological and biochemical events. If protamine 
expression is altered, this could reflect a wide range of spermiogenic defects. 
Indeed, in this study we have identified proteins involved in various aspects of 
spermatid differentiation, sperm maturation and fertilization, sorne of which had 
altered expression following CPA exposure. As weil, sorne of the proteins appear 
to be post-translationally modified, which altered their isoelectric point, and, 
therefore, the 2D gel protein expression profile. 
A few proteins with altered expression were identified that have unknown 
functions during spermiogenesis. PRKRIP1, highly expressed in the testis, is a 
nuclear protein with high nucleolar expression. It acts as a negative regulator of 
PRKR (Yin et al., 2003). Decreased expression the refore, may relieve PRKR 
from inhibition. PRKR, expressed in spermatogonia (Melaine et al., 2003), 
inhibits protein synthesis by phosphorylating the initiation factor, elF-2a 
(Hovanessian, 1989); it has been implicated also in apoptosis (Der et al., 1997), 
cellular transformation (Donze et al., 1995; Meurs et al., 1993), differentiation 
(Samuel et al., 1997) and transcription (Deb et al., 2001; Wong et al., 1997). It 
has been demonstrated that PRKR is involved in the cellular response to 
genotoxic stress, possibly by modulating DNA repair mechanisms to rem ove 
bulky DNA adducts (Bergeron et al., 2000). 
HNRPA1 is a member of a group of core mammalian HNRP proteins that 
bind pre-mRNA and are involved in RNA processing (Krecic and Swanson, 
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1999). Many HNRPs are expressed in germ cells from the spermatogonial to the 
round spermatid phase of development, when RNA synthesis is known to cease 
(Biggiogera et al., 1993); however, the expression of HNRPA1 is restricted to 
spermatogonia (Matsui et al., 2000). Interestingly, the N-terminal end of 
HNRPA 1 is cleaved to produce unwinding protein 1 (UP1), which contains the 
two RNA recognition motifs required for efficient RNA binding (Myers and 
Shamoo, 2004). It is possible that the proteolytic cleavage product present on 
our 2D gels is UP1. Both HNRPA 1 and UP1 are also helix-destabilizing, single-
stranded DNA binding proteins (Nadler et al., 1991). More importantly they are 
involved in telomere biogenesis (LaBranche et al., 1998). Reduced telomere 
length in sperm can affect embryogenesis; if not re-Iengthened, germ cells 
containing shortened telomeres may limit the replication of cells derived from the 
zygote (Baird et al., 2006; Bekaert et al., 2004). Chemotherapeutic agents, 
including drugs such as bleomycin, mitomycin C and CPA, can cause telomere 
shortening (Arutyunyan et al., 2004; Kiyozuka et al., 2000). Increased expression 
of HNRPA1/UP1 may be in response to reduced telomeres in sperm following 
chronic CPA exposure. 
This study used multiple assays to demonstrate that CPA exposure alters 
~ 
sperm chromatin structure and protein expression. Changes in proteins involved 
in sperm function, fertilization, and post-fertilization events important for proper 
embryo development have been shown. An increasing number of groups are 
attempting to identify proteins of the sperm proteome (Chu et al., 2006; Martinez-
Heredia et al., 2006; Pixton et al., 2004). We have used proteomic techniques to 
identify components of rat spermatozoa heads. The results of this study 
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encourage further investigation into changes of the sperm proteome in response 
to exposure to CPA and other male mediated developmental toxicants. The 
clinical significance of these analyses rests in their role in both natural and 
assisted reproduction success rates, and the possibly high prognostic value in 
assessing fertility in cancer patients. 
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Figure 3-1. Susceptibility to acid-induced DNA denaturation in cauda epididymal 
spermatozoa assessed with acridine orange. Cells were collected after 28 days 
of chronic cyclophosphamide exposure, and on days 14, 21 and 28 after sub-
chronic exposure. (A) Extent of DNA denaturation represented by the mean DNA 
fragmentation index (DFI) of cell populations. (B) The percentage of abnormal 
spermatozoa with denatured DNA (%DFI). Black bars, control; gray bars, 
cyclophosphamide. Data shown represent means ± SEM (n=6-8). *Significantly 
different from time-matched controls; # significantly different from sub-chronic 
cyclophosphamide day 14 and 28 groups (p<O.01). 
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Figure.3-2. Chromatin protamination and condensation status of epididymal 
spermatozoa assessed by chromomycin A3 (CMA3) ONA binding. (A) 28-day 
chronic cyclophosphamide-exposed caput and cauda epididymal spermatozoa 
pre-treated with 0, 0.1 and 1mM dithiothreitol (OTT). (A, inset) OTT-dependent 
CMA3 binding in 28-day chronic cyclophosphamide-exposed spermatozoa pre-
treated with 0-20mM OTT. (B) Sub-chronic cyclophosphamide-treated 
spermatozoa collected on days 14, 21 and 28 and pre-treated with or without 
1 mM OTT. Black bars, control; gray bars, cyclophosphamide. Data shown 
represent means ± SEM (n=4). *Significantly different from matched controls; t 
significantly different from control cauda epididymal spermatozoa; ff significantly 
differentfrom cyclophosphamide cauda epididymal spermatozoa (p<0.001). 
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Figure 3-3. Thiol content in heads of caput and cauda epididymal spermatozoa 
after (A) 28-day chronic cyclophosphamide treatment and (B) sub-chronic CPA-
treated spermatozoa collected on days 14, 21 and 28. Measurements were 
taken without dithiothreitol (DIT; free thiols, SH) or with 1 mM DIT pre-treatment 
(total thiols, SS+SH). Black bars, control; gray bars, cyclophosphamide. Data 
shown represent means ± SEM (n=4). *Significantly different from matched 
controls (p<O.001). 
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Figure 3-4. Immunofluorescence assessment of protamine 1 content in cauda 
epididymal spermatozoa pre-treated with or without 1 or 20mM dithiothreitol, 
. (DTT). (A) Images of spermatozoa labeled with HUP1N protamine 1 antibody, 
x400. Parameters measured were (8) fluorescence intensity of spermatozoa, (C) 
spermatozoal head area and (D) fluorescence intensity of spermatozoal heads 
per IJm2. (8-D) 81ack bars, control; gray bars, cyclophosphamide. Data shown 
represent means ± SEM (n=3). *Significantly different from OmM DTT group 
(p<O.05); t significantly different from DTT-matched controls (p<O.01); # 
significantly different from 1 mM DTT group (p<O.001). 
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Figure 3-5. Two-dimensional electrophoretic separation of cauda epididymal 
spermatozoal head basic proteins from (A) control and (8) 28-day chronic 
cyclophosphamide (CPA)-treated rats. Spots unique to each treatment group are 
indicated with blue circles. Red and yellow circles indicate spots showing 
increased or decreased expression compared to the other treatment, 
respectively. Spots with <1.5-fold change in expression are indicated with green 
circles. Protein identification was achieved for spots 1-12 (see Table 3-1). 
MW, molecular weight; pl, isoelectric point. (n=5). 
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Table 3-1 Expression of proteins identified by mass spectrometry 
CPA, cyclophosphamide; HNRPA 1, heterogeneous nuclear ribonucleoprotein A 1; 
PRKRIP1j)redicted, protein kinase R interacting protein 1 (interleukin 11 
inducible) (predicted); CHD4, chromodomain helicase DNA binding protein 4; 
HIST2H4, germinal histone H4; HIST1 H2BL, histone H2B; FABP9, fatty acid 
binding protein 9; ZPBP, zona pellucida binding protein. a Change in expression 
is < 1.5-fold. 
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Protein Spot No. MW (kDa) pl Control CPA % Change Function Localization 
HNRPA1 1 11.8 10.8 0.11 0.18 64 RNAIDNA binding Nucleus/Cytoplasm/Nucleolus 
PRKRIP1_predicted 2 21.5 11.8 2.18 0.76 -65 RNA bindingrrranslationai regulator Nucleolus 
CHD4 3 21.0 11.5 6.63 7.48 13" DNA bindingrrranscriptionai regulator Nucleus 
HIST2H4 4 12.3 11.4 0.86 0.56 _35" DNA binding/Male pronuclear formation Nucleus/Perlnuclear Theca 
5 12.1 11.6 4.26 4.02 -68 
HIST1H2BL 6 14.3 10.8 6.35 5.06 -20· DNA bindlng/Male pronuclear formation Nucleus/Perinuclear Theca 
FABP9 7 15.1 9.1 0.53 1.15 117 Lipid binding/Sperm structure and stability Perinuclear Theca 
8 15.7 9.2 1.50 1.90 27· 
9 15.6 11.5 2.35 1.29 -45 
ZPBP (Sp38) 10 39.7 10.1 1.16 1.39 20· Egg zona pelluclda blndlng Sperm Surface 
11 46.3 11.2 0.37 0.62 68 
Beta-Defensin 20 12 11.8 10.7 0.06 0.13 117 Anti-mlcroblal sperm bindlng protein/ Sperm maturation and capacitation Sperm Surface 
Connecting Text 
On one level, chromatin remodelling during spermiogenesis was affected 
following cyclophosphamide exposure; effects on chromatin condensation were . 
germ cell-phase specific. Oh another level, spermatozoal chromatin structure 
depends on the precise organisation of the DNA into loop domains by mainly 
proteinaceous, nuclear matrix; this structure may serve to regulate gene 
expression. Previously reported altered gene expression in male germ cells and 
early preimplantation embryos following chronic cyclophosphamide exposure 
prompted the development of the last objective of this thesis. T 0 assess whether 
cyclophosphamide affects the sperm nuclear matrix, the next chapter reveals the 
effects chronic cyclophosphamide treatment on the expression of sperm nuclear 
matrix proteins. 
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CHAPTER4 
Chronic Cyclophosphamide Exposure Alters the 
Profile of Rat Sperm Nuclear Matrix Proteins 
Alexis M. Codrington, Barbara F. Hales and Bernard Robaire 
Submitled to Bi%gy of Reproduction 
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4.1 ABSTRACT 
Chronic exposure of male rats to the alkylating agent cyclophosphamide, a 
well-known male-mediated developmental toxicant, alters gene expression in 
male germ cells, as weil as in early preimplantation embryos sired by 
cyclophosphamide-exposed males. Sperm DNA is organized by the nuclear 
matrix into loop domains in a sequence specifie manner. In somatic cells, loop 
domain organization is involved in gene regulation. Various structural and 
functional components of the nuclear matrix are targets for chemotherapeutic 
agents. Consequently, we hypothesize that cyclophosphamide treatment alters 
the expression of sperm nuclear matrix proteins. Adult male rats were treated for 
4 weeks with saline or cyclophosphamide (6.0 mg/kg/day) and the nuclear matrix 
was extracted from cauda epididymal sperm. Proteins were analyzed by two-
dimensional gel electrophoresis. Identified proteins withinthe nuclear matrix 
proteome were mainly involved in cell structure, transcription, translation, DNA 
binding, protein processing, signal transduction, metabolism, cell defense or 
detoxification. Interestingly, cyclophosphamide selectively induced numerous 
changes in cell defense and detoxification proteins, most notably, in ail known 
forms of the antioxidant enzyme, glutathione peroxidase 4, in addition to an 
uncharacterized 54 kDa form; an ove ra Il increase in glutathione peroxidase 4 
immunoreactivity was observed in the nuclear matrix extracts from 
cyclophosphamide-exposed spermatozoa. An increase in glutathione peroxidase 
4 expression suggests a role for this enzyme in maintaining nuclear matrix 
stability and function. These results lead us to propose that a change in 
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composition of the nuclear matrix in response to drug exposure may be a factor 
in altered sperm function and embryo development. 
4.2 INTRODUCTION 
Chromatin structural organization has a significant impact on cel! function. 
Two levels of organization within somatic nuclei, nucleosomal and DNA loop-
domain organization, play a role in gene regulation [1]. The formation of DNA 
loop-domains is of particular interest as DNA is atlached in a sequence-specifie 
manner to the nuclear matrix, the non-chromatin structure of the nucleus [2]. The 
nuclear matrix consists of an internai ribonucleic protein network and residual 
nucleoli bounded by peripheral lamins [3,4]; its interaction with DNA has been 
implicated in many essential nuclear functions, including DNA replication and 
repair, transcription, and RNA processing and transport [5-8]. 
The relationship between nuclear function and organization has been weil 
established in somatic cells [9]; however, the functional significance of sperm 
structural organization remains elusive. Spermatozoal chromatin is not organized 
into nucleosomes; protamines replace histones during spermiogenesis, resulting 
in highly condensed toroids [10]. Interestingly, sperm do maintain the 
organization of DNA by the nuclear matrix into loop-domains [11]. In the mouse 
sperm nucleus, the nuclear matrix forms part of the perinuclear matrix, which 
consists of the surrounding perinuclear theca and a filamentous internai network 
[12]. 
Proteins that make up the nuclear matrix vary in a cel! type- and tissue-
specifie manner and change as cells differentiate [13-16]. Changes also occur in 
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the organization and general protein composition of the nuclear matrix dûring 
spermatogenesis [17,18]. Altering the composition of the nuclear matrix could be 
associated with DNA disorganization; disrupting the association of loop-domains 
with the nuclear matrix may alter nuclear function [19]. Structural and functional 
components of the nuclear matrix are targets in somatic ce Ils for 
chemotherapeutic agents. In somatic cells, alkylating agentsinteract with nuclear 
matrix proteins and with DNA close to matrix-bound replication and transcription 
sites [20-24]. 
Abnormal DNA organization or an unstable sperm nuclear matrix may play 
a role in male factor infertility; under these conditions, embryO development is 
affected [25,26]. We have shown previously that chronic exposure of male rats to 
cyclophosphamide (CPA), a bifunctional alkylating agent, results in pre- and post-
implantation embryo loss, and malformed and growth retarded progeny [27-29]. 
CPA exposure during spermiogenesis and epididymal transit, crucial times during 
male germ cell development as the genome is being remodeled and packaged, 
creates DNA single-strand breaks and crosslinks [30-32] and, notably, results in 
altered gene expression in male germ cells as weil as in early preimplantation 
embryos sired by CPA-exposed males [33-35]. We hypothesize that an action of 
CPA is to affect germ cell function by targeting components of the sperm nuclear 
matrix. 
Many somatic cell nuclear matrix proteins have been characterized [36]. 
However, little is known about the components of the sperm nuclear matrix or the 
precise roles of these proteins in sperm function or embryo development. The 
aim of this study was to use proteomic strategies to identify proteins of the 
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nuclear matrix and to elucidate the effects of chronic CPA exposure on the 
expression of matrix proteins. 
4.3 MATERIALS AND METHODS 
Animal Treatments 
Adult male Sprague-Dawley rats (400-450 g) were obtained from Charles 
River Canada (St. Constant, OC, Canada), maintained on a 14L:10D light cycle 
and provided with food and water ad libitum. Rats were gavaged with saline or 
CPA (6mg/kg/day, CAS 6055-19-2, Sigma-Aldrich Ltd., Oakville, ON, Canada). 
To capture cauda epididymal spermatozoa exposed to CPA throughout 
spermiogenesis and epididymaltransit, animais were euthanized by decapitation 
4 weeks after initiation of treatment [37]. Animal handling and care were done in 
accordance with the guidelines established by the Canadian Council on Animal 
Care. 
Sperm Collection 
Sperm collection was done according to Calvin [38] with modifications. 
Epididymides were first removed, trimmed free of fat and washed in pre-chilled 
phosphate buffer (PB, 20mM, pH 6.0, containing 1 mM EDTA). The cauda region 
was removed, transferred to 8ml of fresh buffer on ice and thoroughly minced 
with sterile scalpels. The tissue was left for 5 min on ice to allow the 
spermatozoa to disperse and was then strained through a BD Falcon 70J,Jm nylon 
cell strainer (VWR International Co., Mississauga, ON, Canada), washed with 
2ml of fresh PB, and the total cell suspension centrifuged at 1000 x 9 for 10 min 
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at 4°C. The pellet was washed once and then resuspended in 4ml of PB 
containing 40J.J1 of protease inhibitor cocktail (P8340, Sigma-Aldrich, Ltd.). Sperm 
were sonicated on ice and sperm heads isolated using discontinuous sucrose 
gradients made with PB. Twelve milliliters of sonicated sperm in 1.80M sucrose 
were layered over 13ml each of cold 2.05M and 2.20M sucrose and centrifuged 
at 91,400 x 9 in a Beckman SW 28 rotor for 70 min at 4°C. The pellet was 
resuspended in PB containing protease inhibitor cocktail (1 :100 dilution) and 
stored at -BOoC. 
Nuclear Matrix Extraction 
Sperm heads were resuspended in 500J.J1 of solution containing 1 % SOS, 
50mM Tris-HCI pH 7.5, 1mM EDTA, and 5J.J1 protease inhibitor cocktail and 
shaken using a Fisher Vortex Genie 2 mixer fitted with a TurboMix attachment 
(VWR International Co.) for 10 min at room temperature. This treatment has 
been shown to remove the acrosome, ail membranes, basal striations, the 
posterior nuclear ring, and the ventral spur of the postacrosomal sheath, leaving 
the condensed nucleus and partially attached perinuclear theca perforatorium, as 
weil as less prominent remnants of perinuclear material in the midlateral and 
posterior regions of the sperm head [38,39]. The samples were then washed 
three times with 50mM Tris-HCI pH 7.5 and resuspended in 500J.J1 of 
decondensation buffer (40mM 1,4-dithiothreitol, 0.25M (NH4)2S04, 25mM Tris-
HCI, pH 7.5, 5J.J1 protease inhibitor cocktail) for 40 min at room temperature. A 26-
1/2G needle was used to gently break up any clumps and 4000U of RNase-free 
deoxyribonuclease 1 (Sigma-Aldrich Ltd.) was added for 60 min at room 
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temperature. Samples used for gel electrophoresis were pelleted, air-dried and 
stored at -20°C or were used immediately for immunofluorescence studies. 
Two-Oimensional (20) Gel Electrophoresis 
Protein separation and gel image analyses were conducted by the McGiII 
University and Genome Quebec Innovation Centre (Montreal, QC, Canada) using 
material from Invitrogen Inc. (Burlington, ON, Canada), except where noted, and 
the Invitrogen ZOOM IPGRunner System protocol. Fifty micrograms of protein 
were resuspended in 155~1 of rehydration buffer (9.8M urea, 10mM 1,4-
dithioerythritol, 4% CHAPS, 20mM Tris) supplemented with 2% IPG Buffer pH 3-
10NL (Amersham Biosciences, Baie D'Urfe, QC, Canada). Seven centimeter 
ZOOM Dry Strips, pH 3-10NL were rehydrated for 16-18 hrs andisoelectric 
focusing (IEF) done with a voltage gradient (200V- 2000V) applied as 
recommended by the manufacturer. After IEF was complete, strips were 
equilibrated with 1X NuPAGE LOS Sam pie Buffer, containing 2% OTT and then 
alkylated with iodoacetamide. Both steps were done at room temperature for 15 
min. Electrophoresis in the second dimension was done on 4-12% Bis-Tris 
precast mini-gels in XCeli SureLock Mini-Cells filled with MOPS SOS Running 
Buffer. Broad range protein molecular weight markers (0.9 J,Jg/gel, Amersham 
Biosciences) were used and 200V were applied for 50min. Gels (n=3 each for 
control and treated) were fixed overnight in 50% methanol/10% acetic acid, silver 
stained, scanned and analyzed using Phoretix 2004 Image Analysis software 
(Amersham Biosciences). Following background subtraction and normalization, 
intensities of the spots were calculated. One gel was then chosen as a reference 
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and the other gels compared to the reference gel to create an average control 
and CPA gel, which were then compared. Spots were considered if present in at 
least two out of three gels and protein expression was considered changed only if 
the difference was at least 2-fold; this is equivalent to an increase of 100% or 
decrease of 50%. 
Mass Spectrometry 
Spots were excised from the gel and subjected to trypsin digestion on a 
robotic MassPREP Station (Waters-Micromass, Milford, MA, USA), as per the 
manufacturer's instructions. Gel pieces were first washed twice with water for 20 
min, destained twice in a 120".11 solution of 30mM potassium ferricyanide and 
100mM sodium thiosulfate mixed 1: 1 for 15 min and then dehydrated with 751-11 of 
100% acetonitrile. Samples were reduced, in the dark, with 501-11 of 10mM OTT 
for 30 min followed by alkylation with 501-11 of 55mM iodoacetamide for 20 min and 
1001-11 of 100% acetonitrile for 5 min. After washing and dehydration in 100mM 
ammonium bicarbonate and 100% acetonitrile, respectively, gel pieces were 
covered and digested for 4.5 hours with 6 ng/I-II of trypsin go Id (Promega, 
Madison, WI, USA) in 100mM ammonium bicarbonate. Peptides were extracted 
with 301-11 formic acid (FA) solution (1% FA in 2% acetonitrile) for 30 min, twice 
with 121..J1 FA solution and then 121-11100% acetonitrile for 30 min. 
Nanoflow chromatography of digested peptides was done on an Agilent 
1100 series nanopump (Agilent Technologies Inc., Mississauga, ON, Canada) at 
a flow-rate of 200nl/min. Sam pie injection and desalting were performed with an 
Isocratic Agilent 1100 series pump at 151..JI/min for 5 min. A trapping column 
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(Agilent) packed with Zorbax 300SB-C18 (5 x 0.3 mm) was used for sam pie 
desalting. Peptide separation was done with a Biobasic C18 (10 x 0.075 mm) 
picofrit column (New Objective, Woburn, MA, USA). Peptides were eluted using 
a 20 min gradient with solvent A (0.1 % FA) and solvent B (95% 
acetonitrile:0.1%FA) from 90%Al10%B to 100%B. 
Electrospray mass spectrometry was done with a 4000 Q TRAP System 
(Applied Biosystems/MDS Sciex, Foster City, CA, USA). Enhanced MS scans 
were acquired between 350-1600 m/z using a scan speed of 4000 amu/sec and 
active dynamic filt time. Information-dependent MS/MS analysis was performed 
on the three most intense multiply charged ions; a dynamic exclusion of 90 sec 
was used to limit resampling of previously selected ions to two events. Three 
averaged MS/MS scans were acquired between 70-1700 m/z at a scan speed of 
4000 amu/sec. Fixed fill time was set at 20 ms with QO trapping and rolling 
collision energy of .±. 3 eV. Peaklists for peptide mapping searches were 
generated with Mascot script 1.6 for Analyst 1.4.1 software (Applied 
Biosystems/MDS Sciex). Spectral processing included peak smoothing and 
centroiding without de-isotoping. Database searches were done with Mascot 1.9 
(Applied Biosystems/MDS Sciex) using carbamidomethyl cysteine as a fixed 
modification, methionine oxidation as a variable modification, and 1.5 Da 
precursor mass and 0.8 Da fragment mass tolerances. 
Glutathione Peroxidase 4 (GPX4) Immunoblotfing 
Immediately after electrophoresis in the second dimension, unstained gels 
were transferred to Hybond-P polyvinylidene difluoride (PVDF) membrane 
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(Amersham Biosciences), using the Invitrogen XCeli1i Blot Module and protocol. 
Briefly, the blot module, gel and membrane were assembled and inserted into the 
XCeli SureLock Mini-Cell. The module was filled with NuPAGE Transfer Buffer 
(Invitrogen) supplemented with 10% methanol and protein transfer was done at 
30V for 1 hr. Efficiency of protein transfer was confirmed by staining blots with 
Ponceau S (Sigma-Aldrich Ltd.). Following destaining in deionized water, 
membranes were air dried and stored at room temperature. When ready to use, 
the membrane was washed in 100% methanol for a 2 seconds, followed by 10 
min in 20mM Tris-HCI pH 7.6, containing 0.8% NaCI and 0.1 % Tween-20 (TBS-
T). Membranes were then blocked for 1 hr at room temperature in 5% non-fat 
milk in TBS-T, washed for 2 min in TBS-T and then incubated overnight at 4°C 
with rabbit polyclonal anti-GPX4 (Abcam Inc., Cambridge,MA, USA) diluted 
1 :20000 in TBS-T containing 3% non-fat milk. After two brief washes with TBS-T, 
membranes were washed once in 40ml for 15 min and twice in 20ml for 10 min 
with TBS-T. Membranes were then incubated for 1 hour at room temperature 
with horseradish peroxidase-conjugated rab bit IgG antibody (Amersham 
Biosciences) diluted 1:15000 in TBS-T containing 5% non-fat milk and washed. 
Antibody detection was done using the ECL Plus Western Blotting system 
(Amersham Biosciences). 
GPX41mmunofluorescence 
GPX4 immunoreactivity was determined in sperm collected after 
incubation in 1 % SOS or after nuclear matrix extraction. Ten microliter droplets 
were placed on slides and left on ice for 20 min. Siides were then washed in 
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PBS (3 x 2 min), fixed in 2% paraformaldehyde for 20 min at room temperature, 
washed and blocked with PBS containing 5% normal goat serum (Vector 
Laboratories Inc., Burlington, ON, Canada) and 1% bovine serum album in (BSA, 
Sigma-Aldrich, Ltd.) for 30 min at room temperature. Subsequently, cells were 
covered overnight at 4°C with primary antibody solution containing 1 % BSA and 
rabbit polyclonal GPX4 antibody (1 :20 dilution) in PBS, washed with PBS (3 x 5 
min), covered for 1.5 hrs in the dark at room temperature with secondary 
antibody solution containing Alexa Fluor 488 conjugated goat anti-rabbit IgG 
antibody (1 :200 dilution, Invitrogen) in PBS, and finally washed in PBS. Slides 
were covered with Vectashield mounting medium containing DAPI (Vector 
Laboratories Inc.) and kept at 4°C in the dark. Pictures were taken using a 
DAGE-MTI CCD300-RC camera (DAGE-MTI Inc., Michigan City, IN, USA) 
atlached to an Olympus BX51 epifluorescence microscope. 
4.4 RESULTS 
20 Gel Analysis of Sperm Nuclear Matrix Proteins 
Sperm nuclear matrix proteins analyzed by 2D gel electrophoresis resulted 
in reproducible protein patterns. Three gels each were run for control and 
chronic CPA-treated sperm protein samples; protein profiles differed with 
treatment (Figure 4-1). The average control gel (Figure 4-1A) consisted of 290 
protein spots that appeared in at least two out of the three gels analyzed and 
corresponded to 90-96% of the total number of spots detected on individual gels. 
ln comparison, 309 protein spots were found on the average CPA gel (Figure 4-
1 B), corresponding to 94-98% of ail spots appearing on individual gels. Overall 
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changes in protein expression are iIIustrated in Figure 4-2A. The expression of 7 
protein spots (2%) was unique to control samples and 26 (8%) to CPA samples. 
Two hundred and eighty-three protein spots were expressed in both groups; 
analysis of protein expression changes> 2-fold revealed 34 spots (11 %) that 
increased and 38 (12%) that decreased following CPA exposure. 
Thirty-two spots were chosen for mass spectrometry from each 
expression group (increased, decreased, control-specifie, CPA-specific and no 
change). Twenty-four spots were identified, as labeled in Figure 4-1 and 
summarized in Table 4-1. Selection was based on: 1) spots present in charge-
trains, such as spot 5; 2) spots located in the acidic region where other somatic 
nuclear matrix proteins have been previously identified, such as spots 7-12; and 
3) spots that consistently appeared on ail three gels, such as spots 4 and 24. 
The majority of identified spots was either increased in expression or unique to 
CPA samples; none were unique to control sperm and spot 2 was the only one 
that decreased (by 67%). Ten of the identified proteins were represented byat 
least two distinct spots on the gels, suggesting that these proteins are modified or 
exist in different isoforms (for example L1M domain containing preferred 
translocation partner in lipoma (LPP), in spots 3 and 4, or GPX4, found in spots 
5, 16, 17, 18, 19, 20, 21 and 23). Thirteen spots matched to more than one 
protein (for example, analysis of spot 24 gave significant results for 
phosphatidylethanolamine binding protein, PEBP; proteosome (prosome, 
macropain) subunit, beta type 6, PSMB6; and similar to Ran-interacting protein 
MOG-1 (predicted». Of note, protein fragments were identified from significant 
mass spectrometry analysis results for peptides that only partially covered a 
178 
protein sequence. Despite the use of protease inhibitors during sample 
preparation, these protein fragments may be proteolytic cleavage products. 
Analyzed spots for three proteins (heterogeneous nuclear ribonucleoprotein K, 
HNRPK; regulator of telomere elongation helicase 1, RTEL 1; and 
spermidine/spermine N1-acetyl transferase (mapped» contained only a fragment 
of the identified proteins; the mass of the proteins calculated from the 2D gel was 
below the expected mass of the proteins, calculated from their amino acid 
compositions. 
Based on information in the nuclear matrix NMP-db database [40] and in 
the literature, 11 of the identified proteins are known nuclear matrix components 
(HNRPK, GPX4, PSMB6 and protein phosphatase 1, catalytic subunit, gamma 
isoform; PPP1 CC) or are related to previously identified nuclear matrix proteins 
(DnaJ (Hsp40) homolog, subfamily B, member 6, DNAJB6; glutathione-S-
transferase omega 2, GST02; glutathione-S-transferase mu 5, GSTM5; heat 
shock 70kDa protein 2, HSPA2; RTEL 1; and proteosome (prosome, macropain) 
subunit, alpha type 5, PSMA5 and beta type 4, PSMB4). Along with GPX4, 
HNRPK, and PPP1 CC, glutathione-S-transferases and DnaJ (Hsp40) proteins, 
are expressed in nucleoli; ail except for PPP1 CC have been identified in spots 
that mainly increased in expression following CPA exposure or were specifie to 
CPA-exposed sperm. These proteins may be a part of nuclear matrix residual 
. nucleoli; these are known to be present in somatic cells [3,41]. 
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Functional Analysis of Identified Proteins 
Surprisingly, only 7 of the 24 identified proteins were previously identified 
as components of spermatozoa heads (GPX4, HSPA2, calicin, DNAJB6, PEBP, 
capping protein (actin filament) muscle Z-line, beta (CAPZB), and testis-specific 
serine kinase 2 (TSSK2», while 4 others have other known roles in 
spermatogenesis in the testis (GST02, GSTM5, PPP1 CC and RTEL 1). 
Information concerning the putative functions of the proteins was found in the 
NCBI non-redundant and SWISS-PROT protein sequence databases or in the 
literature. In general, the proteins are involved in cell structure, transcription and 
translation regulation, DNA binding, protein processing, signal transduction, 
metabolism, cell defense and detoxification (Table 4-1). The unknown proteins 
have not yet been characterized. 
Out of the three structural proteins identified, calicin is a known component 
of the sperm head perinuclear theca [42,43]. Spot number 4, containing calicin 
and growth-arrest-specific 2 (GAS2), increased by 1850% after CPA exposure 
compared to control. There was no change in the expression of CAPZB; 
however, it migrated higher then its calculated molecular weight of 32 kDa. 
Despite this discrepancy, CAPZB was accepted as a positive identification since 
multiple significant peptide matches were found following mass spectrometry 
analysis. Morphological assessment of whole mature spermatozoa following 
chronic CPA exposure showed that cells were normal and that such treatment did 
not appear to affect the stability of the nuclear matrix, as the structure after 
extraction (confirmed by negative DAPI staining) was intact (Figure 4-2B). 
180 
GPX4 Expression 
Surprisingly, cell defense and detoxification proteins were present in 
abundance on the 2D gels. CPA induced changes in the amount of ail known 
forms of the antioxidant enzyme, GPX4; in addition, an uncharacterized 54 kDa 
form was identified (Table 4-1). Mass spectrometry results were confirmed by 
western blotting and revealed the full effect of CPA on GPX4 expression (Figure 
4-3). Charge-trains between 20 and 31 kDa were observed with an apparent 
ove ra Il increase in expression after CPA treatment compared to controls. Distinct 
spots were clearly different between control and CPA blots (Figure 4-3, open 
arrows). In particular, a form of GPX4 at -54 kDa is shown in the CPA blot 
(Figure 4-38, black arrow) and an increased am ou nt of the 34 kDa post-
translationally modified form of GPX4 was detected (Figure 4-3, arrowhead); this 
form has been shown to be localized to the nucleoli of spermatogonia, 
spermatocytes and spermatids [44]. 
Figure 4-4 further validates the results obtained by mass spectrometry and 
confirms the presence of GPX4 in the nuclear matrix. For comparison, 
membrane-free sperm heads treated with 1 % SDS were immunostained (Figure 
4-4A). Not only was there increased GPX4 immunoreactivity in CPA-exposed 
samples compared to controls but also this increased immunoreactivity was 
found in the sperm nuclear matrix extract. Interestingly, immunoreactivity was 
greater in SDS-treated samples compared to the respective nuclear matrix 
extracts (Figure 4-48). Thus, these results indicate that CPA-treatment resulted 
in an increase in chromatin-bound GPX4, as weil as matrix-specific increased 
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expression. Omission of the primary antibody resulted in an absence of 
immunoreactivity (data not shown). 
4.5 DISCUSSION 
The nuclear matrix is a dynamic structure with a morphology and protein 
composition that varies with the functional state of the nucleus [45]. It has been 
possible to identify specifie cell and tissue types by the electrophoretic pattern of 
their nuclear matrix proteins [14-16]. Both normal and neoplastic samples can be 
identified by differences in nuclear matrix protein patterns [46]. The present 
study is the first to go beyond structural evaluation and extensively examine the 
rat spermatozoal nuclear matrix by identifying sorne of the protein components. 
Significantly, we have demonstrated that exposure to an alkylating agent and 
male-mediated developmental toxicant alters the spermatozoal nuclear matrix 
protein profile. A major transition in sperm chromatin structure and function 
occurs during spermiogenesis, resulting in the formation of mature spermatozoa 
competent to fertilize. Changes reported in the nuclear matrix structure and 
protein profile of round and elongating spermatids reflect the morphological 
changes and remodeling of chromatin that occur during spermatid differentiation 
[17]. Our results show that targeting germ cells throughout spermiogenesis with 
CPA modifies the make-up of the nuclear matrix. Such an effect may alter 
chromatin reorganization by the nuclear matrix both during spermatogenesis and 
in the zygote after fertilization. 
Interestingly, there was no apparent effect of CPA exposure on the 
structure of the nuclear matrix. Calicin and F-actin capping proteins like CAPZB 
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are known components of the sperm head perinuclear theca, possibly involved in 
sperm morphogenesis and stability, and F-actin organization and biogenesis, 
respectively [42,47]. GAS2 has been implicated also in actin filament 
organization [48]; hyperphosphorylation and proteolytic c1eavage at its C-terminal 
end result in an irregular cell shape and actin rearrangement, processes which 
are triggered as part of a series of apoptotic events [49]. Overexpression of other 
cytoskeletal proteins results in a change in actin organization; however, this is not 
the case with overexpressed GAS2 [48], as we see in this study. We did not 
identify any of the previously described classical cytoskeletal proteins found in 
somatic cell matrices, such as vimentin, keratin or actin, or the perinuclear lamins 
A, 8 and C [50,51]; interestingly, actin, myosin, cytokeratins and spectrin have 
been described in the guinea pig sperm nuclear matrix [52]. 
Previous studies report differential expression of stress response genes in 
male germ cells after chronic exposure of male rats to CPA [33]. Factors other 
than matrix instability may alter DNA organization and, subsequently, affect gene 
function. Alkylating agents preferentially' bind to matrix proteins and matrix-
associated DNA [23,24]. Proteins are most likely to give rise to multiple spots as 
a consequence of multiple post-translational modifications; most eukaryotic 
proteins are modified and these modifications are often essential for their function 
[53]. In this study, some differences in expression are probably due to 
modification of the nuclear matrix proteins following drug exposure. Tew and 
colleagues [21] have shown that fibrillar components of the matrix and 
ribonucleoproteins are alkylated following exposure to 1-(2-chloroethyl-3-
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cyclohexyl)-1-nitosourea (CCNU) and chlorozotocin, but the effects of these 
modifications on protein function are not known. 
Reduced binding of DNA to the matrix may be a function of interference 
with the DNA recognition sites by alkylation at specifie bases; in vitro alkylated 
DNA has a reduced interaction with matrix proteins [21]. Chromatin loops 
associate with the nuclear matrix at specifie regions called matrix attachment 
regions (MARs) [54]; these MARs are involved in DNA replication and repair and 
in various aspects of gene regulation [55], including mRNA transcription and 
processing via their involvement in attachment and/or association with newly 
transcribed mRNA, pre-mRNA splicing machinery and ribonucleoprotein particles 
[56]. In light of this,two proteins, HNRPK and LPP that were present at elevated 
levels in the nuclear matrix extracted from CPA-exposed sperm are of particular 
interest. HNRPK is a unique member of the heterogeneous nuclear 
ribonucleoprotein (hnRNP) family that preferentially binds single-stranded DNA 
[57]. It acts as a docking site to integrate signaling cascades between anchored 
protein complexes and, as such, is a multifunctional molecule implicated in 
transcription activation and chromatin remodeling, in addition to the more typical 
hnRNP functions of mRNA splicing, transport and translation [58]. Studies on 
LPP demonstrate that it has the capa city to activate transcription and suggest 
that, like HNRPK, it may serve as a scaffold upon which protein complexes are 
assembled [59]. 
Increased expression of GPX4 in the nuclear matrix was intriguing, given 
its role not only as an intracellular antioxidant enzyme, directly reducing lipid 
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hydroperoxides [60], but also in apoptosis inhibition [61], œil cycle regulation 
[62], and embryo development [63]. Most interestingly, in spermatozoa GPX4 
appears to have two functions: 1) protamine disulfide crosslinking, where it uses 
the protamine cysteine residues instead of glutathione as reductants and acts as 
a thiol peroxidase when bound to DNA, and 2) protection of sperm against 
oxidative damage [64]. 
Sperm nuclear GPX4 has a molecular weight of 34 kDa and is bound to 
DNA. However, once spermatozoa reach the caput epididymal region, about 
two-thirds of the 34 kDa enzyme is processed into smaller proteins, with 
molecular masses between 22 and 29 kDa, that do not bind to DNA; their 
enzymatic properties are not affected [64,65]. A 20 kDa form, identical to 
cytosolic GPX4, is also present in heads of spermatozoa [65]. Each of these 
forms was present in our extracts. The nucleoli in mature spermatozoa are 
inactive; only nuclear vacuoles containing fibrils remain [66]. Work done by 
Puglisi [67] showed that GPX4 localizes to fibrous material in electron-Iucent 
spots in condensed epididymal sperm; these could be areas of residual nucleoli. 
A nucleolar GPX4 with a molecular mass of 34 kDa has also been identified in 
the nucleoli of spermatogonia, spermatocytes and spermatids [44]. 
Under normal conditions, GPX4 appears to be present within the head of 
spermatozoa both bound and unbound to DNA and, to a lesser extent, in the 
nuclear matrix; GPX4 expression increases following CPA exposure. Exposure 
to CPA or acrolein, a metabolite of CPA, induces the formation of reactive oxygen 
species (ROS) (68,69] and lipid peroxidation [70]. Sperm are highly susceptible 
to lipid peroxidation, and the induction of ROS is correlated with decreased 
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capacity to undergo the acrosome reaction [71] and DNA damage [72]. 
Increased nuclear expression of GPX4 may contribute to antioxidant defense 
mechanisms; however, functions served by localization of GPX4 to the nuclear 
matrix are less evident. In somatic ce Ils , overexpression of nucleolar GPX4 
protects nucleoli from oxidative stress-induced damage [44]. Additionally, lipids 
are not only membrane components, but also represent important components of 
chromosomes, chromatin and the nuclear matrix [73]; sorne studies suggest that 
they are involved in DNA loop atlachment to the nuclear matrix, replication, 
transcription as weil as nuclear signal transduction [73-75]. If this is the case in 
sperm nuclei, CPA may induce oxidative stress and lipid peroxidation that may be 
reduced by GPX4. 
Changes in protein composition, or modifications thereof, may correlate 
with alterations in DNA organization, leading to changes in DNA function and 
protein expression. Changes in protein expression could be important in the 
regulation of sperm function. The impact on the post-fertilization early embryo 
remains to be determined; however, one effect may be ectopic protein expression 
in fertilized eggs. Studies on preimplantation embryos sired by CPA-treated 
males report temporal and spatial disruption of the rat zygotic genome activation; 
total RNA synthesis was higher and gene expression profiles were altered as 
early as at the 1-cell stage in comparison to controls [34,35,76]. 
This study provides further insight into the mechanisms by which CPA may 
exert its male-mediated effects on embryo development. The identification of 
sperm nuclear matrix components and their functions brings us closer to 
unraveling the mysteries of the matrix. 
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FIGURES and LEGENDS 
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Figure 4-1. Two-dimensional electrophoretic separation of cauda epididymal 
spermatozoal nuclear matrix proteins from (A) control and (8) 4-week chronic 
cyclophosphamide (CPA)-treated rats. Spots unique to each treatment group are 
indicated with blue circles. Red and yellow circles indicate spots showing 
increased or decreased expression following CPA exposure, respectively. Spots 
with <2-fold change in expression are indicated with green circles. Protein 
identification was achieved for spots 1-24 (see Table 4-1). 
MW, molecular weight; pl, isoelectric point. 
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Figure 4-2. (A) Overall changes in the expression of 316 nuclear matrix proteins 
spots following 4-week chronic cyclophosphamide (CPA) treatment. >100% 
increase (horizontallines), >50% decrease (black), control-specifie (white), CPA-
specifie (cross-hatch), and no change «2-fold change in spot intensity, diagonal 
lines). Numbers in parenthesis = the number of spots in each category. (8) 
Phase contrast images of whole spermatozoa and nuclear matrix extracts (top 
panels). DNA stained with DAPI (bottom panels). Original magnification X400. 
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Figure 4-3. Two-dimensional western blots probed with an antibody to 
glutathione peroxidase 4 (GPX4). (A) Control and (B) 4-week chronic 
'cyclophosphamide (CPA)-treated nuclear matrix samples. Open arrows: 
Immunoreactive spots that clearly differ with treatment. Black arrow: 
Uncharacterized 54 kOa GPX4 form. Arrowhead: Post-translationally modified 
and increased expression of 34 kOa form. 
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Figure 4-4. Expression of glutathione peroxidase 4 (GPX4) in (A) SDS-treated 
membrane-free spermatozoa and (B) sperm nuclear matrix extracts. Left panels: 
Control. Right panels: 4-week chronic cyclophosphamide-treated sperm. 
Samples (n=3) were immunostained with anti-GPX4. Original magnification 
X400. 
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Table 4-1. Expression of proteins identified by mass spectrometry. 
a Values represent spot intensities; b % Change in expression; * Change in 
expression is < 2-fold; CAPZB, capping protein (actin filament) muscle Z-line, 
beta; DNAJB6, DnaJ (Hsp 40) homolog, subfamily B, member 6; GAS2, growth-
arrest-specific 2; GPX4, glutathione peroxidase 4; GSTM5,glutathione-S-
transferase mu 5; GST02, glutathione-S-transferase omega 2; HNRPK, 
heterogeneous nuclear ribonucleoprotein K; HSPA2, heat shock 70kDa protein 2; 
LPP, UM domain containing preferred translocation partner in lipoma; 
MGC156832, similar to BTB/POZ domain containing protein 6; PCBP1, poly(rC) 
binding protein 1; PEBP, phosphatidylethanolamine binding protein; PPP1 CC, 
protein phosphatase 1, catalytic subunit, gamma isoform; PSMA5/B4/B6, 
proteosome (prosome, macropain) subunit, alpha type 5/beta type 4/beta type 6; 
RTEL 1, regulator of telomere elongation helicase 1; SAT _MAPPED, 
spermidine/spermine N1-acetyl transferase (mapped); TSSK2, testis-specific 
serine kinase 2; TPI1, triosephosphate isomerase 1. 
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Function Protein Spot No. M,x 10.3 pl Controla CP A a b % Change 
Cell structure CAPZB 7 45.8 6.0 0.54 0.67 24* 
8 47.8 7.1 0.36 0.49 36* 
10 40.2 7.0 1.35 1.41 4* 
12 37.4 6.1 1.09 1.67 53* 
Calicin 4 74.1 9.3 0.12 2.34 1850 
GAS2 4 74.1 9.3 0.12 2.34 1850 
TranscriptionITranslation LPP 3 74.1 7.2 0.39 0.71 82* 
4 74.1 9.3 0.12 2.34 1850 
HNRPK 23 20.4 8.3 0.02 0.18 800 
PCBPI 8 47.8 7.1 0.36 0.49 36* 
DNAbinding RTELl 16 25.4 7.5 0.10 0.45 350 
17 25.4 7.6 0.56 CP A-specifie 
Protein processing DNAJB6 5 53.9 8.9 0.15 0.60 300 
6 47.8 9.2 0.80 1.05 31* 
HSPA2 3 74.1 7.2 0.39 0.71 82* 
PSMA5 13 27.1 4.4 0.09 0.20 122 
PSMB4 22 23.3 7.2 0.04 CPA-specific 
PSMB6 24 21.1 5.3 0.51 0.69 35* 
Signal transduction PPP 1 CC 7 45.8 6.0 0.54 0.67 24* 
8 47.8 7.1 0.36 0.49 36* 
9 42.7 6.0 0.71 0.93 31* 
TSSK2 6 47.8 9.2 0.80 1.05 31* 
PEBP 24 21.1 5.3 0.51 0.69 35* 
Metabolism SAT_MAPPED 3 74.1 7.2 0.39 0.71 82* 
TPIl Il 37.4 5.8 0.69 1.13 64* 
12 37.4 6.1 1.09 1.67 53* 
Cell defenselDetoxification GPX4 5 53.9 8.9 0.15 0.60 300 
16 25.4 7.5 0.10 0.45 350 
17 25.4 7.6 0.56 CP A-specifie 
18 26.5 8.6 0.26 CPA-specific 
19 24.1 6.0 0.10 0.23 130 
20 24.3 6.1 0.09 0.23 155 
21 22.4 6.5 0.65 0.80 23* 
23 20.4 8.3 0.02 0.18 800 
GST02 14 29.3 8.4 2.31 3.86 67* 
GSTMS 15 26.6 6.8 0.47 0.79 68* 
16 25.4 7.5 0.10 0.45 350 
17 25.4 7.6 0.56 CPA-specific 
18 26.5 8.6 0.26 CPA-specific 
21 22.4 6.5 0.65 0.80 23* 
Unknown Sirnilar to Ran-interacting 24 21.1 5.3 0.51 0.69 35* 
protein MOG 1 (predicted) 
MGCI56832 7 45.8 6.0 0.54 0.67 24* 
8 47.8 7.1 0.36 0.49 36* 
Similar to KlAAI683 113.5 9.2 0.43 0.90 109 
2 115.9 9.4 0.43 0.14 -67 
Similar to hypothetical protein 6 47.8 9.2 0.80 l.05 31* 
DKFZp434H2215 (predicted) 
CHAPTER 5 
Discussion 
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At least 50% of ail conceptions are estimated to result in fetal loss before 
the end of the first trimester (Goldstein, 1994; Wilcox et al., 1999). This figure is 
most likely underestimated since many spontaneous abortions happen very early 
in a pregnancy, before a woman may even know she is pregnant (Jauniaux et al., 
1996). Evidence from animal studies clearly indicates that male-mediated effects 
on reproduction, particularly following paternal exposure to a drug, may include 
an increased incidence of early spontaneous abortions; in humans, such an 
effect would likely go unnoticed and be diagnosed as idiopathic infertility. 
Cyclophosphamide is a prime example of a male-mediated developmental 
toxicant with >80% early post-implantation loss reported in embryos sired by 
male rats exposed to the drug during post-meiotic germ cell development (Trasler 
et al., 1987). How or why this occurs was the basis for the studies of this thesis. 
The W.H.O. uses seven parameters for semen analysis (WHO, 1999); 
however, these have been proven in many circumstances to be non-predictive of 
fertility potential or more importantly, ability to support embryonic development. 
There is now a battery of assays that extend beyond the scope of the W.H.O. 
normal semen criteria to evaluate sperm quality and function (Agarwal and 
Allamaneni, 2005; Aitken, 2006). The studies presented in this thesis highlight a 
few of these which contribute to our understanding of the mechanisms of 
cyclophosphamide action in the male germ cell. The paternal genome is key to 
successful embryo development and, collectively, the results of the present 
studies show that cyclophosphamide alters male germ cell chromatin structure at 
both the DNA and protein javel. In this final chapter, the significance of this work 
in terms of its relevance in and advancement of the field will be discussed. 
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5.1. Sperm Genetic Integrity 
The results of chapter two clearly show that chronic cyclophosphamide 
exposure has a great impact on the genetic integrity of sperm nuclei. Most 
striking, are the differential susceptibilities of spermiogenic germ cells to 
cyclophosphamide-induced DNA damage; the consequences of such effects on 
gene expression, in particular on the transcriptional state of the male gamete, are 
intriguing. 
The beginning of spermiogenesis is characterized by a wave of 
transcriptional activity which results in the activation of numerous essential post-
meiotic genes in early spermatids (Dadoune et al., 2004). Alkylating agents, 
including cyclophosphamide, induce DNA structural modifications by creating 
strand breaks and DNA-DNA or DNA-protein crossHnks; these modifications can 
delay or stop RNA polymerases, resulting in truncated RNA molecules (Masta et 
al., 1995; Tornaletti and Hanawalt, 1999). Interestingly, there is no detectable 
damage in epididymal spermatozoa after early round spermatids were exposed 
to acute or repeat doses of cyclophosphamide. Assuming that damage is 
induced by this treatment, the results imply that round spermatids have the ability 
to repair any damage incurred. If this were the case, then the synthesis of 
transcripts would not be affected. In chapter three, however, we showed that the 
expression of proteins critical to sperm function, fertilization and embryo 
development was still altered in the mature sperm. Another mechanism affecting 
gene expression may be at the level of translation; cyclophosphamide may alter 
transcript quality by RNA alkylation. Previous in vitro studies have shown that 
nitrogèn mustards have the capability to inhibit translation, resulting in truncated 
211 
polypeptides (Masta et al., 1995). This is interesting considering that protein 
fragments were identified in the 2D gels used in our experiments in chapters 
three and four. 
Due to the highly condensed architecture of mammalian sperm chromatin, 
the male gamete is rendered transcriptionally silent late in spermiogenesis 
(Kierszenbaum and Tres, 1975). Interestingly, several studies have reported the 
presence of RNA transcripts in human ejaculated spermatozoa (Ostermeier et al., 
2002; Ostermeier et al., 2004; Wykes et al., 1997) and mouse mature 
spermatozoa (Wykes et al., 2000). One study clearly proves that mature human 
spermatozoa cannot transcribe novel RNA (Grunewald et al., 2005). It has been 
suggested that these sperm transcripts may be remnants of stored testicular 
transcribed RNAs that were not translated and that were retained as a 
consequence of nuclear shutdown or that they may play a more active role in 
post-fertilization eventsas essential paternal RNAs required for embryo 
development (Ostermeier et al., 2004). The effect of xenobiotic exposure on the 
quality of the transcripts is of concern if the possibility exists that they may 
participate in embryogenesis. 
Cyclophosphamide maximally damaged DNA at its most vulnerable state 
during mid-spermiogenesis, when nucleoproteins are in the process of 
exchanging histones for protamines and therefore leave the genome temporarily 
open to cyclophosphamide atlack. Both transcription and translation are ongoing 
in elongating spermatids (Steger, 1999). Most importantly, DNase-1 
hypersensitivity regions have been located within step 12-13 elongating 
spermatids; these regions have been associated also with transcriptionally active 
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genes near nuclear matrix sites (Gross and Garrard, 1988; McPherson and 
Longo, 1992). In somatic cells, alkylating agents preferentially bind to DNA near 
matrix-bound transcription sites (Muenchen and Pienta, 1999). It is tempting to 
speculate that cyclophosphamide alkylation may also target specifie gene loci 
within these regions; these genes may be required for early embryo 
development. Analysis of RNAs from spermatozoa of infertile men is being used 
as a diagnostic tool for identifying germline mutations in candidate infertility-
associated genes (Yatsenko et al., 2006). Interestingly, previous studies from 
our laboratory report increased transcript levels in elongating spermatids 
following acute and chronic dosing regimes using cyclophosphamide (Aguilar-
Mahecha et al., 2001; Aguilar-Mahecha et al., 2002). It remains to be determined 
whether these transcripts persist in the mature rat spermatozoon; nevertheless, 
this approach could be used to characterize the RNA of rat spermatozoa, should 
any be present, following cyclophosphamide exposure. By altering the integrity 
of genomic DNA, the drug may subsequently affect the expression and quality of 
the RNA synthesized during mid-spermiogenesis and still present in mature 
spermatozoa. These transcripts may, in fact, be required for post-meiotic events 
including sperm condensation, maturation, fertilization or embryogenesis. 
5.2. Sperm Chromatin Structure and Proteome 
ln chapter three, the use of multiple assays demonstrated that 
cyclophosphamide exposure alters sperm chromatin structure, with effects 
specifically on thiol and protamine content. The results of this study tie in very 
weil with previous reports which have shown that the male pronucleus forms 
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earlier in embryos sired by cyclophosphamide-treated male rats than in those 
sired by controls (Harrouk et al., 2000). Transcriptional activation of specifie 
genes is initiated after fertilization and remodelling of the sperm chromatin after 
fertilization is fundamental for the expression of the paternal genome (Schultz, 
2002). Interestingly, earlier male pronuclear formation was also followed by 
alterations in the gene activation program; bromouridine-triphosphate (BrUTP) 
incorporation into RNA and Sp1 transcription factor immunostaining increased in 
2-cell embryos sired by cyclophosphamide-treated males compared to controls 
(Harrouk et al., 2000). Our findings are relevant since less condensed sperm 
present in newly fertilized eggs could be the reason for more rapid 
decondensation, pronuclear formation and zygotic gene activation with 
detrimental effects on embryo development. 
Proteomic tools can be used to analyze sperm proteins important for 
sperm development and proper embryo development. Recently, there have been 
a few reports using the present proteomic technology to identify proteins present 
in the mature germ cell (Chu et al., 2006; Martinez-Heredia et al., 2006; Pixton et 
al., 2004). Chapters three and four used 20 gel electrophoresis and subsequent 
mass spectrometry to assess two different fractions of sperm, the sperm head 
basic proteome and nuclear matrix. To my knowledge, these studies are the first 
to analyze sperm in this manner, as weil as to determine the effects of xenobiotic 
exposure on protein expression. 
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5.2.1. Sperm Head Basic Proteome 
, 
The exchange between histones and protamines is a carefully regulated 
and complex process. Studies have demonstrated that the expression of 
protamines 1 and 2 is uniquely regulated by transcription and translation factors, 
including storage of the mRNA in RNP particles in the cytoplasm until translation 
initiation (Dadoune, 2003; Steger, 2001). Recent studies have indicated that 
infertile men with abnormal protamine levels have either decreased protamine 
transeript levels, thereby affecting the P1/P2 ratio (Steger et al., 2003), or 
elevated levels of protamine transcripts in mature sperm (Aoki et al., 2006), 
indicating a possible defect in transcription or translation. There are several 
possible mechanisms which may be responsible for the dysregulation of 
protamine expression. Whatever the meehanism may be, the problem could be a 
global issue and not just protamine expression-specifie. For example, such 
abnormalities may be indicative of a defeet in mRNA storage and/or translation 
overall which, in turn, may affect other mRNA transeripts. Sperm chromatin 
condensation defects in general may be indicative of a wide range of 
spermiogenic anomalies. Following ehronic eyclophosphamide exposure, we 
saw that the sperm basic proteome was indeed affected. Identified proteins were 
involved in spermatid differentiation, sperm maturation and fertilization. The 
results of this study incite further investigation into the proteins of the sperm 
head, not just with 2D gel protein identification, but also with immunofluorescence 
and functionality assays in order to completely characterize proteins of interest 
involved in germ cell and embryo development. This approach would allow for 
the potential identification of biomarkers specific to the male-mediated effects of 
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drug exposure. For example, PRKRIP1, is highly expressed in the testis yet has 
no known spermiogenic function (Yin et al., 2003). Its novelty is exciting. It is a 
negative regulator of the protein kinase, PRKR which has been implicated in 
many cellular functions, including translation (Hovanessian, 1989), transcription 
(Oeb et al., 2001) and differentiation (Samuel et al., 1997), as weil as ONA repair 
(Bergeron et al., 2000); any one of these roles could be critical to the 
development and function of the male germ cell. Cyclophosphamide exposure 
resulted in decreased expression of PRKRIP1 compared to control spermatozoa. 
Given the multiple roles played by PRKR, future studies focused on either protein 
could prove them to be important factors in the mechanisms of 
cyclophosphamide action. 
5.2.2. Nuclear Matrix Proteome 
Research into the relationship between the development of cancer and 
nuclear matrix aberrations has been fundamental in establishing biomarkers used 
as prognostic tools for neoplastic diseases (Leman et al., 2003). Whether 
biomarkers of sperm defects can be established and used to elucidate the 
reasons behind male-mediated developmental toxicant effects on progeny 
outcome remains to be seen with great anticipation. The nuclear matrix is known 
to be important for normal cellular functions such as transcriptional regulation and 
ONA replication (Anachkova et al., 2005; Mortillaro et al., 1996; van Oriel et al., 
1991). Clearly the sperm nuclear matrix is important for embryo development 
since studies have reported that sperm nuclei with disrupted nuclear matrix 
structures cannot participate in embryogenesis (Ward et al., 1999). Sperm 
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nuclear DNA is apparently organized in such a way that it contains heritable 
information required for development (Sotolongo and Ward, 2000); this 
organization may template the paternal genome for use in the early post-
fertilization embryo (Kramer and Krawetz, 1996). If this is indeed the function of 
the sperm nuclear matrix th en questions naturally emerge concerning the 
proteins that make up the nuclear matrix. What is it that makes the nuclear 
matrix so important? To date, the proteins of the spermatozoa nuclear matrix 
have not been examined extensively nor has the impact of exposure to drugs on 
their structure or function been determined. Chapter four serves to answer this 
question. The expression of several matrix proteins was altered following chronic 
cyclophosphamide exposure and, for the first time, a number of the proteins were 
identified. 
Of utmost interest is the increased or cyclophosphamide-specific 
expression of nucleolar proteins following drug exposure. The nucleolus is the 
ribosomal biogenesis center where ribosomal RNA (rRNA) genes are transcribed. 
Nucleolar inactivation commences in early round spermatids; rRNA synthesis 
gradually decreases as spermiogenesis progresses to the point where nucleoli 
disappear in parallel with the cessation of RNA synthesis in elongating 
spermatids (Schultz and Leblond, 1990). The use of specifie antibodies directed 
against nucleolar proteins, including ribosomal proteins, hnRNPs and fibrillarin, 
only results in positive immunolabeling of fibrillarin in spermatid residual nucleoli 
(Biggiogera et al., 1994). The increased expression of nucleolar-specific proteins 
in our experiments leads me to speculate that nucleolar inactivation may be 
disrupted. 
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It would be fascinating to examine sperm nucleolar inactivation during 
spermiogenesis following cyclophosphamide exposure. Important end points to 
consider would be the persistent expression of the nucleolar proteins mentioned 
above, including the prime nucleolar marker, nucleolin. As weil, ultrastructural 
evaluation of spermatid nucleoli would be helpful. Preliminary experiments in our 
laboratory not only indicate increased expression of nucleolin in mature 
spermatozoa following chronic cyclophosphamide exposure, but also differential 
localization of the protein from what appears to be the acrosomal or 
subacrosomal region in control sperm to the nucleus in cyclophosphamide-
exposed sperm. Further experiments are necessary to confirm these findings. 
Additionally, increased expression of the 34 kDa form of glutathione peroxidase 4 
(GPX4) was observed. Interestingly, this protein is expressed in the nucleoli of 
spermatids; these findings spur great curiosity into their function in this organelle. 
Overexpression of GPX4 in somatic cells has a protective role in that nucleoli are 
protected from oxidative-stress induced damage (Imai et al., 1996). It is tempting 
to speculate that the spermatid nucleolus may be prevented from degrading due 
to the increased expression of GPX4 following cyclophosphamide exposure. 
Additional experimentation is necessary to resolve this mystery. 
Correspondingly, should the nucleolus still be active in mature sperm, one might 
expect dysregulated nucleogenesis and, consequently, altered gene expression 
in the early embryo which is exactly what our laboratory has discovered using 
similar chronic cyclophosphamide dosing regimes (Harrouk et al., 2000); the 
formation of the nucleolus after fertilization is temporally regulated and is 
essential for embryonic protein synthesis and viability. 
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5.3. DNA Organization 
A plethora of information can be gained from examination of the nuclear 
matrix protein profile. While further work can be done to identify additional 
proteins within the proteome, future directions of this work should include 
investigation of the actual organization of DNA within mammalian sperm nuclei, 
with particular emphasis on whether drug treatment affects the organization of 
DNA loops by the matrix. One route which can be taken to accomplish this goal, 
is visualizing, by fluorescence in situ hybridization (FI8H), the structural 
organization of specific DNA segments. 
Changes in individual DNA loop domains can be visualized in nuclear halo 
preparations by FI8H using probes to specific genes of interest. Changes in 
DNA loop organization have been shown to occur based on the functional state 
of the cell in question (Gerdes et al., 1994; larovaia et al., 2005). Probes to 58 
rDNA have been used successfully for studying changes in complete loop 
domain structures during spermatogenesis (Klaus et al., 2001; Nadel et al., 
1995). The beauty of this technique is that it is possible to distinguish between 
actively transcribing genes, which are more likely to be associated with the 
nuclear matrix as a single focus, and inactive genes, which would extend into the 
nuclear halo (Gerdes et al., 1994; larovaia et al., 2005). The same can then be 
true in sperm; even if they are not transcriptionally active, changes in DNA loop 
attachment due to drug exposure may be visible. Probes for 58 rDNA and other 
candidates, such as paternally imprinted genes, would be likely choices to start. 
Interestingly, the expression of imprinted genes was altered in embryos sired by 
cyclophosphamide treated males; expression peaked in 2-cell embryos 
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compared to a peak in expression of these genes not observed until the 8-cell 
stage in control embryos (Harrouk et al., 2000). Previous reports suggest that 
DNA loop domain organization is specifically regulated during spermatogenesis 
and embryogenesis (Klaus et al., 2001). Using 5S rDNA probes, it has been 
shown that DNA organization changes during spermacytogenesis and 
spermatidogenesis; however, it does not appear to change during 
spermiogenesis (Klaus et al., 2001). At this stage, the loop domains may be set 
in place, thus suggesting that they may be important in the function of the 
paternal genome in the newly fertilized zygote, for DNA replication and/or RNA 
transcription. If this is the case and this structure is altered following drug 
exposure then the consequences to the embryo would be detrimental. 
Collectively, the results of this thesis contribute to our understanding of the 
susceptibility of male germ cells to damage at the DNA and protein level and the 
consequent diminished quality of the male germ cell following cyclophosphamide 
exposure. The necessity of an intact and stable paternal genome to support 
embryo development is also highlighted in the studies presented. These 
analyses are indeed also clinically significant for the diagnosis and treatment of 
male infertility. Finally, the data collected cou Id potentially be used towards the 
discovery of future therapeutic interventions and male contraceptive targets. The 
findings presented in this thesis should act as a catalyst to delve deeper into 
unraveling the mechanisms of male-mediated developmental toxicity. 
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List of Original Contributions 
1- 1 have developed the cornet assay under alkaline conditions for rodent 
spermatozoa. In particular, by using this assay, 1 have identified the 
consequences of cyclophosphamide exposure on the genetic integrity of 
individual sperm nuclei, thus revealing that there are heterogeneous populations 
with varying degrees of DNA damage. 
2- Cyclophosphamide exposure results in dose-dependent and time-specific 
increases in the levels of DNA damage measured in epididymal spermatozoa, 
evidenced by acute, subchronic and chronic dosing regimens. 
3- The extent of DNA damage incurred in spermatid nuclei is germ cell phase-
specifie; mid-spermiogenic elongating spermatids are most susceptible to DNA 
damage following cyclophosphamide exposure. 
4- Chronic exposure to cyclophosphamide alters the epididymal sperm 
chromatin structure; sperm have limited disulfide and protamine content and 
reduced chromatin stability. 
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5- Sy using subchronic doses of cyclophosphamide 1 was able to expose the 
germ cell specifie effects of the drug on chromatin structure. Altered chromatin 
structure, determined by increased susceptibility to in situ denaturation and 
reduced thiol content in sperm, was most evident in epididymal spermatozoa 
exposed to the drug during mid spermiogenesis. 
6- Classical use of chromomycin A3 analysis, used to detect abnormal chromatin 
packaging in protamine-depleted spermatozoa, failed to reveal an affect in rat 
spermatozoa exposed to cyclophosphamide. However the method 1 have 
developed shows that, in addition to protamine deficiency, chromomycin A3 
binding in the rat depends on the thiol or decondensation status of the ce Il , thus 
this fluorochrome can be used to measure the effect of drug exposure on 
chromatin packaging providing spermatozoa are first decondensed. 
7- 1 have uniquely designed a method using two-dimensional basic gels to 
characterize the basic proteome of spermatozoal heads which shows that chronic 
cyclophosphamide exposure alters the proteome make-up. Proteins identified 
are involved in transcription and translation regulation, chromatin organization, 
sperm structure and stability and fertmzation and thus could be essential for 
normal sperm function and embryo development 
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8- My studies were the first to demonstrate that xenobiotic agents can alter the 
sperm nuclear matrix; chronic cyclophosphamide exposure affects the expression 
of the nuclear matrix proteome in epididymal spermatozoa and therefore could 
affect the potential role of the matrix in gene regulation. 
9- 1 have expanded the current knowledge of sperm nuclear matrix proteins by 
identifying a number of the components. From the proteins identified 1 have 
shown that the functions of sorne of the sperm nuclear matrix proteins include 
involvement in cell structure, transcription, translation, DNA binding, protein 
processing, signal transduction, metabolism, cell defense and detoxification. 
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